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An alternative major research project (Appendix 3) had been identified and planned between 
October 2018 and March 2020. In March 2020, major disruptions to NHS services occurred 
because of the COVID-19 pandemic and made the proposed MRP project untenable. Due to 
restrictions relating to the pandemic (closure of services and restriction on non-essential 
research) I was unable to proceed with the approvals necessary to commence recruitment 
within the William Quarrier Scottish Epilepsy Centre. In addition, the centre discharged all 
patients and halted its services for a significant period. The original project was therefore 
abandoned. As a result of these changes, and in line with guidance provided by the University 
of Glasgow, I chose to seek approval for a new project utilising an existing data set. The data 
provided for this study came from the William Quarrier Scottish Epilepsy Centre, it is a dataset 




I would like to say a gracious thank you to my supervisors, Professor Tom McMillan and Dr Iain 
Campbell for their guidance and support with the planning and completion of this research, 
especially as it came down to the wire.  
 
To my family, Mom, Dad and my dearest sister Dr Zoe who have offered so much encouragement 
and support to get to this point, thank you for always believing in me. A special thank you goes 
to friends, new and old, near and far for their kindness and motivation. Gal groups, run clubs, 
climbing humans, and least of all flatmates; without you none of this would have been possible. 
  
 6 
Chapter 1 Systematic Review 
 
Associates of quality of life in individuals with psychogenic non-epileptic seizures 
 







Quality of life (QOL) in those who experience psychogenic non-epileptic seizures (PNES) is low 
compared to individuals with epilepsy and other clinical cohorts. Treatment should aim to 
improve QOL alongside reducing clinical symptoms as it has been noted that cessation of PNES 
symptoms does not necessarily improve quality of life significantly. There has been an expansion 
of the literature with a number of cross-sectional studies focusing on identifying and measuring 
the associations between various social and psychological factors with QOL in PNES and an 
updated review is warranted.   
 
Objective 
This review aims to examine the available evidence on the various psychological, social and 
physical factors that contribute to QOL in individuals with PNES in order to guide clinical practice 
and future research.  
 
Methods 
Databases were systematically searched for research published on associates of QOL in 
individuals with PNES. The Crowe Critical Appraisal Tool Version 1.4 was used to assess the quality 
of the studies by the author and a subset was examined by a second rater. 
 
Results 
Sixteen papers were identified and included. The quality of the articles was judged to be 
moderate to high. Methodological weaknesses identified were small sample size, failure to use 
appropriate diagnostic procedures (VEEG) and lack of diversity in sampling methods which largely 
drew on individuals in tertiary settings, limiting the generalisability of results.  Seizure frequency 
was not found to be associated with QOL. Anxiety, depression and more generic measures of 
psychological distress account for a significant amount of the variance within QOL. Demographic 
characteristics of age and gender did not show strong evidence for association with QOL. Social 
factors appear to be associated with QOL and carer wellbeing has influence on QOL in the PNES 
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population. There is evidence for the importance of assessing patient QOL and psychological 
distress as it is a consistent predictor of QOL. 
 
Conclusion 
Individuals with PNES are likely to benefit from routine screening of anxiety and depression and 
offered suitable treatment in line with national guidance on managing anxiety and depression in 
the wider population, regardless of the setting. Social and carer factors appear to influence QOL 




Psychogenic Non-Epileptic Seizures (PNES) are behavioural events and experiences that typically 
disrupt consciousness, can cause collapse and/or produce jerking limb and body movements 
(Hubsch et al., 2011). The descriptive term “Non-Epileptic Seizure” refers to the absence of 
abnormal, evolving cortical activity that distinguishes PNES from Epileptic seizures. The term 
“Psychogenic” indicates that these are presumed then to originate from psychological 
mechanisms. One prominent theory hypothesises that PNES and their behavioural constituents 
(of which there are many forms) occur following the activation of a “seizure scaffold” and as a 
dissociative type response to threatening internal or external events (Roberts & Reuber, 2014).  
PNES is not a formally recognised diagnostic label but the episodes of PNES that many individuals 
experience often meet the diagnostic criteria of Dissociative Disorder (World Health 
Organization., 2005) or Conversion Disorder (American Psychiatric Association. & American 
Psychiatric Association. DSM-5 Task Force., 2013). 
 
Results from both quantitative and qualitative studies indicate that PNES are typically associated 
with a negative impact on health and wellbeing (Gregg H. Rawlings, Brown, Stone, & Reuber, 
2018). Traditional outcome measures in clinical practice and research have focused on 
investigator reported impressions, test results or clinical indicators such as frequency, intensity, 
duration and onset. However, it is becoming increasingly important to acknowledge individual 
experiences via patient reported outcome measures when measuring the impact of PNES on 
physical and mental health (Devlin & Appleby, 2010). Measures can be general or disease specific 
and should aim to gain a representation of the patient’s health status directly from the individual, 
without interpretation by others.  
 
Health related quality of life or quality of life (QOL) as it may also be referred to in the literature 
is a construct that assesses a patient’s physical functioning, emotional status and social well-
being (Power et al., 1998). When compared to patients with epileptic seizures and the general 
population, individuals with PNES consistently report lower QOL (Al Marzooqi, Baker, Reilly, & 
Salmon, 2004; Myers, Lancman, Laban-Grant, Matzner, & Lancman, 2012; Szaflarski, Hughes, et 
al., 2003; Testa, Schefft, Szaflarski, Yeh, & Privitera, 2007). Clinical interventions for both epilepsy 
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and PNES often focus on reduction of seizure frequency. A systematic review by Taylor, Sander, 
Taylor, and Baker (2011) found that seizure frequency was the most commonly reported 
predictor of QOL for individuals with epilepsy. Increased seizure frequency was shown to have a 
negative association with QOL scores in 21 out of 26 studies. In their review, they report the 
negative predictive effect of increased seizure frequency on QOL appeared to be consistent 
across anti-epileptic drug managed and refractory populations” (p. 2171). B. Jones, Reuber, and 
Norman (2016a) conducted a review of QOL in individuals with PNES and found that only two out 
of six studies found patients with more seizures had significantly lower QOL scores. Other studies 
in their review found no correlation between QOL and seizure frequency and those that did, 
became non-significant after controlling for other variables such as depression.  As such it 
appears that seizure reduction is not likely to have a significant impact on QOL for individuals and 
that as B. Jones et al. (2016a) suggest, interventions for PNES should focus on the myriad of other 
factors that appear to be associated with QOL. 
 
B. Jones et al. (2016a) suggest that physical symptoms, age of PNES onset and cognitive 
complaints are correlated with QOL in individuals with PNES. They report finding depression to 
be the strongest correlate of QOL. Anxiety was found to be significantly associated with QOL in 
correlation analysis but not within multiple regression with covariates analysis. Dissociation was 
found to be negatively associated with QOL, and they also report the influence of family members 
to be a significant association. The authors cite limitations to these results owing to concerns 
about the methodological quality of the evidence identified. Almost all the studies included in 
the review employed a cross sectional design (which is not uncommon in PNES research) and 
none of the studies satisfied all three of the quality appraisal criteria applied by the authors. The 
quality criteria were (1) Consecutive or random selection of patients (an index of sample and 
response bias). (2) Statement of a formal sample size calculation or a target sample size of 115 
or more to detect a relatively small association (correlation coefficient of .3 at 5% alpha and 90% 
power). (3) Multivariate analysis (an index of level of confounding risk/variables). Most studies 
within the review did make some attempt to control for confounding variables by utilizing 
multiple regression analysis.  
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A search of the literature revealed no update on the B. Jones et al. (2016a) review. There has 
been an expansion of the literature with a number of cross-sectional studies focusing on 
identifying and measuring the associations between various social and psychological factors with 
QOL in PNES.  This update can be used to guide clinical practice in the identification and treatment 
of factors which are likely to lead to the improvement in QOL in a group of individuals who are 
reported to have poor QOL and multiple vulnerabilities.  
 
Research Questions:  
This review updates B. Jones et al. (2016a) by investigating: 
(1) What is the methodological quality of studies researching QOL in PNES? 
(2) Are there seizure related or other clinical factors associated with QOL in PNES? 
(3) Are there individual demographic factors associated with QOL in PNES? 
(4) Are there psychological factors associated with QOL in PNES? 
(5) Are there social factors associated with QOL in PNES? 
Method 
This systematic review follows the Preferred Reporting Items for Systematic Reviews and Meta-
analyses guidelines (Moher, Liberati, Tetzlaff, Altman, & Group, 2009). Searches of the Cochrane 
Database of systematic reviews were completed to find previous literature reviews on QOL in 
PNES. In addition, PROSPERO, the international prospective register of systematic reviews was 
searched for related reviews. The review protocol was then developed and registered with 




The search strategy replicates that of B. Jones et al. (2016a), using APA Psyc Articles, APA Psych 
Info, CINAHL, Medline and Psychology and Behavioral Sciences Collection (OVID Host). EBSCO 
Host was used to search Chicano. Although three categories of search terms were used by B. 
Jones et al. (2016a) their third subject was omitted (correlation\predictor research) as this 
removed relevant papers in the search. The following search terms were employed: 
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Non-epileptic (seizure*, attack*, episode*, disorder) or psychogenic (seizure*, attack*, episode* 
non-epileptic) or pseudo (seizure*, attack*, episode*) or "unintended seizure*”  
 
And  
“Quality of life” or “Health related quality of life” or “quality of life measures” or HRQOL or QOL 
or wellbeing or “well-being”, “well being"  
 
Search terms were combined using Boolean operators “AND”, “OR”, “n2” and ”n3”. Truncations 
(denoted by an asterisk) were employed to ensure all search terms following the truncation were 
identified. A manual search of reference lists of the included articles was carried out to identify 
any further pertinent studies and a manual search on Google Scholar was conducted using key 
terms and prominent researchers in the field.  
 
Inclusion Criteria were studies published: 
(1) in English 
(2) in peer reviewed journals 
(3) from 1st November 2014 to 31st January 2021  
(4) describing original data 
(5) including individuals aged 16 years and over with a diagnosis of PNES, probable PNES or co-
occurring PNES and epilepsy 
(7) with any research design if assessing QOL with a validated tool and reporting an association 
correlation or regression with any other measured factor 
 
Exclusion criteria were studies: 
(1) investigating participants with PNES and co-occurring functional movement disorder or 
broader somatoform disorder 




The Crowe Critical Appraisal Tool (CCAT) was used to assess the quality of the studies (Crowe, 
Sheppard, & Campbell, 2011). The tool has good construct validity and inter-rater reliability with 
an intraclass correlation coefficient of 0.83 for combined research designs (Crowe et al., 2011). 
There is no specified cut-off score for the CCAT. The tool recommends consideration of individual 
criteria scores is important to interpretation of quality (Crowe, 2013). Brown and Reuber (2016) 
outlined four key aspects of study design and four key aspects of sample characteristics that are 
considered to be important in assessing methodological quality of PNES research. These authors 
designed a PNES research quality appraisal tool which went through a number of iterations 
before demonstrating good interrater reliability (Cohen’s Kappa) of k=0.73. It has since been used 
in a number of systematic reviews, but not specifically in the review of QOL associations with 
PNES. Brown and Reuber’s (2016) quality appraisal criteria were utilised within this review to 
further structure the “Design” and “Sampling” criteria of the CCAT.   
 
Within the “Design” section, specific consideration was given for the following criteria:  
1. Video electroencephalography (VEEG) for allocation of participants into PNES groups 
2. Consecutive sampling (as opposed to convenience) 
3. Standardized outcome measures 
4. Matching of participants between groups on age and gender. Matched participants are 
defined as less than or equal to 5 years difference between mean age and less than or 
equal to 10% difference in number of females within the groups.   
Within the “Sample” section, specific consideration was given for the following criteria: 
1. Explicit reference to the exclusion of participants with epilepsy from the PNES sample 
2. Explicit reference to the use of a procedure to distinguish PNES from alternative 
psychiatric diagnosis such as conversion disorder, syncope or anxiety. 
3. Explicit reference to the exclusion of PNES from control or epilepsy samples 
4. Sample size greater than 26 participants. This was decided as very few studies within the 
literature conduct power analysis\sample size calculations. Brown and Reuber suggest 
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rating sample size adequacy with reference to the commonly-used power and effect size 
conventions suggested by Cohen (1988). Sample sizes for case–control studies with less 
than 26 participants in each group (i.e., < 80% power to detect a large effect size, d = 0.8, 
assuming a two-tailed independent t test with alpha = .05) were not awarded a mark.  
Incorporating these quality appraisal criteria does not alter the structure or scoring of the CCAT. 
Rather it provides specific considerations within the existing quality appraisal of design and 
sample and meets the recommendation that specific attention be paid to individual criteria 
scores within the tool. Final scores were assigned by way of CCAT scoring. The studies were rated 
high, moderate, low or very low quality based on arbitrary cut-offs (high: greater than 90%, 
moderate: 75-89%, low: 60-74%, very low: less than 60%). A second trainee psychologist rated a 
random subset (n=2) of the studies independently, to ensure appropriate use of the CCAT. 
Agreement of final scores of the CCAT was moderate as assessed by Cohen’s kappa (k= .606, 
p=<.001). Differences in ratings were resolved via discussion. 
 
Search Results  
A total of 1046 articles were initially identified via database searches and a further five through 
hand search. After duplicates were removed and the remaining titles and abstracts were 
screened, the eligibility criteria were applied to 111 full articles. A further 95 articles were 
excluded and the remaining 16 were included in the review (Figure 1). Data was extracted using 





Figure 1. PRISMA Flowchart of the article identification and selection process 
Articles retrieved from database searching 
n=1046 
Articles retrieved from additional sources 
n=5 
Total retrieved articles n=1051  Duplicates removed n= 271 
Articles screened by title or abstract 
n=780 
Articles excluded (n=669  )  
reason 1 = completely irrelevant sample 
reason 2 = QOL measure not used 
Articles screened by full text  
n=111 
Articles excluded (n=95 )  
Did not use PNES sample, n = 40 
Review Article, book chapter, Single cases, 
pediatric sample, n= 32 
Association of QOL and other factor was not 
measured n = 23 





























Articles methods appraised 
n=16 
Articles excluded (n=0)  
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Results 
Participants and Settings 
In total, 1139 people with PNES and 45 Carers of people with PNES were reported across the 16 
studies (Table 1). This number excludes studies that reported on overlapping samples (Green, 
Norman, & Reuber, 2017; Karakis, Janocko, et al., 2020; Karakis, Morton, et al., 2020; Wardrope, 
Green, Norman, & Reuber, 2019). The mean age of people with PNES across 12 studies was 39, 
two studies reported median age and were not included in the calculation (Novakova, Howlett, 
Baker, & Reuber, 2015; G. H. Rawlings, Brown, & Reuber, 2017). Across the studies, 727 
participants (64%) were female.  
 
Recruitment of participants across the studies was most frequently from general and specialist 
neurology settings. This was from Epilepsy Monitoring Units (EMU) in eight studies (Avalos et al., 
2020; Boesten, Myers, & Wijnen, 2019; Cohen, Testa, Pritchard, Zhu, & Hopp, 2014; Karakis, 
Morton, et al., 2020; Latreille, Baslet, Sarkis, Pavlova, & Dworetzky, 2018; Salinsky et al., 2019; 
Walther et al., 2020; Wolf et al., 2015), neurology outpatient clinics in five studies (Clegg, Sirois, 
& Reuber, 2019; Gagny et al., 2021; Green et al., 2017; Karakis, Janocko, et al., 2020; Wardrope 
et al., 2019) and from both EMU and neurology outpatients in one study (Karakis, Janocko, et al., 
2020). One further study recruited from a psychology clinic, treating patients referred from 
tertiary neurology services (Novakova et al., 2015).   
 
The participants recruited from these settings may not be representative of the PNES population 
as individuals with PNES are also seen in non-specialist settings. Two studies did recruit 
participants from non-specialist settings; Robson et al. (2018) recruited from online support 
groups for people with PNES and  G. H. Rawlings et al. (2017)  recruited from both neurology 
outpatient clinics and online support groups.  
 
Outcome Measures 
Outcome measures in the reviewed studies included the epilepsy specific measures “Quality of 
Life in Epilepsy” (QOLIE versions 10/31) and “Quality of Life in Newly Diagnosed Epilepsy” 
(NEWQOL-6D). Two general measures of QOL were also used, the 36 or 12 item Short Form 
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Health Survey (SF-12/36) and the European Quality of Life–3 Dimensions Scale (EQ-5D-3L). 
Although these measures are validated and demonstrate good reliability in their intended 
populations, none have been validated in people with PNES and in fact no PNES specific QOL 
measures were identified outside of these review articles.  
 
Study Quality 
The methodological quality of the studies ranged from 63% to 93%. The majority of studies being 
rated as moderate or high quality. All studies scored four or five marks on the preliminary and 
introduction scores, indicating no major threats to quality stemming from these sections. 
Regarding the ethics section, one study lost marks due to the use of descriptions that could 
potentially lead to identification of participants (Novakova et al., 2015). 
 
Only half the studies utilised VEEG confirmation of PNES diagnosis (Avalos et al., 2020; Boesten 
et al., 2019; Cohen et al., 2014; Gagny et al., 2021; Karakis, Morton, et al., 2020; Latreille et al., 
2018; Wolf et al., 2015). The use of VEEG is important to the validity of results. One study (Robson 
et al., 2018) included participants with co-occurring epilepsy and PNES and so results in this study 
may not be representative of individuals with PNES only or epilepsy only. A further three studies 
did not indicate exclusion of those with co-occurring diagnoses (Latreille et al., 2018; Novakova 
et al., 2015 and Gagny et al., 2021). The PNES, epilepsy and control samples across the remaining 
studies were otherwise well controlled and defined.  
 
All studies utilised consecutive sampling and standardised outcome measures which was a 
strength. Gagny et al.  (2021) only utilised scores from the Overall Quality of Life subscale of the 
QOLIE-31 which only comprises two questions and note this as a limitation. Two of twelve studies 
that included comparison groups demonstrated matched groups as per Reuber and Brown (2016) 
criteria (Latreille et al., 2018; Salinsky et al., 2019). The remaining studies were marked down on 
this aspect of bias due to having a higher percentage of females in the PNES groups. Two studies 
reported a priori sample size estimation. Three studies had a low sample size according to the 
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Brown and Reuber (2017) criterion of n<26 (Green et al., 2017; Walther et al., 2020; Wardrope 
et al., 2019). 
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QOLIE-31 total score was inversely correlated 
with LSS (r= −0.42**) 
caregiver stigma (r=−0.8****) 
 
Lower QOLIE-31 score predicted higher 
Patient LSS (partial R² =0.18**), it was the 
only predictor of Patient LSS. 
 
Lower patient QOL scores predicted higher 
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QOLIE-31 total score was inversely correlated 
with: 
ESS (rS = - 0.474***). 
Seizure frequency (rs = - 0.382, ***). 
 
QOLIE-31 – showed Non-significant 
correlations with: 
Duration of PNES (rs = 0.111 ns)  
Time from onset to diagnosis (rs = 0.066 ns) 
Participant’s age (rs = 0.062 ns). 
 
ESS was significantly correlated with 5 of the 
7 QOLIE-31 subscales: 
(Weight r) 
Seizure worry (rs= -0.479***) 























Social functioning (rs= -0.407***) 
Cognitive (rs= -0.314***) 
Energy and fatigue (rs= -0.252**) 
 
QOLIE-31 was not significantly correlated with 
subscales: 
Medication effects (rs= -0.146 ns) 







4 Wardrope et 





















































Patient QOLIE-10 was correlated with carer 
SF-12 (Mental Wellbeing subscale) (r= 0.646*) 
 
QOLIE-10 total score demonstrated non-
significant correlations following holm- 
Bonferroni correction with: 
Carer anxiety (r = −0.025 ns)  
Carer Depression (r= −0.191 ns)  































































No significant correlations between QOLIE-10 
and depression, anxiety, duration or 
frequency of PNES, relationship quality or 
attachment styles. 
 
Due to non-significant correlation results, no 
regression analyses were performed for the 
PNES group data. 
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change in QOL. 
 
QOLIE-31 and SF-36 Mental and Physical 
Subscales not significantly correlated with 
gender, seizure frequency or associated 
epilepsy at time of diagnosis. 
SF-36 (Physical Scale) correlated with: 
Age at diagnosis, β = -.572***  
IQ (β = 0.285 ns). 
 
QOLIE-31, SF-36 Mental and Physical Scales 
were all significantly correlated with:  
MADRS, All p ≤ 0.001 
HAM-A, All p < 0.001 
DES, P <  0.005 
TAS, p ≤ 0.001 
 
Regression  
Physical Health was associated with:  
age at diagnosis (β = -0.429*) 
IQ value (β = .475**) 
 
Mental and Physical SF-36 showed significant 
association with anxiety (respectively -
0.783** and -1.012***) 
 
Depression significantly associated with 
QOLIE-31 (-0.863**) and SF-36 Mental Scale (-
0.639*).  
 













PTSD (mental SF-36: β = -13.838**, physical 
SF-36: β = -8.774*). 
 
A negative correlation between SF-36 Mental 
Scale and emotional abuse (β = -1.071**) but 
not in physical SF-36 dimension. No relation 
was found using “overall QoL” dimension of 
QOLIE-31 with period of life when the trauma 
occurred. 
 
 Number of mental health consultation 
attended was the only significant predictor of 
change in “overall quality of life” of QOLIE-31 
(p = 0.02). The more mental health 
consultations the individual attended, the 
greater the QoL appeared with Odds Ratio, 











































No significant correlation between NEWQOL-
6D and gender, age, education, duration or 
frequency of seizures. 
 
Significant correlation between NEWQOL-6D 
and: 
psychological distress (r=-0.58***) 
anxiety (r=-0.54***) 
depression (r=-0.54***)  






































The final model accounted for 61.9% of the 
variance in NEWQOL-6D scores. At stage one, 
demographic factors explained 3% (ns, p = 
0.53) of the variance at stage two, condition 
factors (frequency and severity) accounted for 
a further 10.9% (ns, p=0.1). Psychological 
distress accounted for 24.8%*** and at stage 
four, illness perceptions accounted for 
23.3%*, with personal control as a significant 
























































A significant negative correlation between 
depression and QOL (r = −0.66****, r²=0.43). 
 
 A significant correlation was found between 
























































QOLIE-31 was significantly correlated with: 
PNES diagnosis (r = -.21**) 
Alexithymia (r=-.39***) 
Somatization (r=-.64***) 
Abuse (r =-.13 ns) 
Trauma (r= -.18 ns) 
 
Alexithymia significantly predicted lower 
quality of life β =−.30*** CI (−.43,−.17). Across 
combined PNES and Epilepsy groups.  
 
Diagnosis did not predict the direct effect on 
quality of life, β =−2.63 (NS. p=.11) CI (−5.85, 
.58). 
 
In the model of somatization, diagnosis did 
not predict quality of life directly, β = .80 (ns, 
p = .61) CI (−2.27, 3.86). 
 
Diagnosis was associated with greater 
somatization in PNES group β = 8.82*** CI 
(4.73, 12.90).  
 
A one-point increase in SOM significantly 
decreased quality of life by .46 points, β = 
−.46*** CI (−.57, −.35).  
 
The total indirect effect of SOM as a mediator 
between diagnosis and quality of life was 







−2.23) indicating that SOM significantly 
mediated the relationship 




























































The SF-36 mental health Scale was correlated 
with all the measures: 
 
EPS (r= -.702**), 
PHQ-15 (r= -.478**),   
CORE-10 (r= -0.89**)  
BIPQ (r= -.697**).  
 
The SF-36 Physical Health Scale was 
significantly correlated with: 
 
PHQ-15 (r= -.476**) 
BIPQ (r=-0.442, p<0.01)  
 
but not significantly correlated with: 
 
EPS (r= 0.088 ns) 
CORE-10 (r=-0.085 ns) 
 
The SF-36 Mental Health Scale and Physical 




























































There was no significant correlation between 
Self Compassion and QOL in people with PNES 
















































Squared for the 
proportion of 
variance 




Traumatized patients on average scored 
lower than the non- traumatized group on the 
QOLIE-31 total score and Energy sub score.  
 
MANCOVA indicated a significant difference 
for age (p= .001) and years of education (p= 
.001) and not sex (p = .321) indicating poorer 














was present or 
not based on 
self-reported 
data of the 
patients). 
 




























































In veterans with PNES, QOLIE-31 scores were 
significantly correlated with: 
 
Employment (r= 0.32**) 
Years of Seizures (r=0.29**) 
BDI-II (r=-0.72***) 
PTSD Checklist (r= -0.57***) 
Number of axis I diagnoses (r= -0.35**) 
MMPI-2RF RC1 (r=-0.55***). 
 
QOLIE-31 Score was not significantly 
associated with age at admission, age of 
seizure onset, gender, education, driving 
ability, receipt of disability allowance, any 
military factors or seizure related factors 
(deployment, combat, years in service, 
combat experience scale) or the presence of 
any Axis II diagnoses.  
 
In the final regression Model,  
























Significant predictors of QOLIE-31 were. 
Driving (adjusted r²= 0.17*)  
 
BDI-II (adjusted r²= =-0.58***) 
 
MMPI-2 RC1 (adjusted r²= 0.29**) 
 
Age at admission, years of education, 
employment, number of seizures, years of 
seizures, PTSD Checklist, number of axis I 
diagnoses, and presence of axis II diagnoses 











































Regression QOL measures only accounted for 1.2% and 
5% of the variance in dissociative experiences 
scores. Compared to 83.3% accounted for by 
all the variables (BSI, BAI, BDI-II, Lorig Self-
Efficacy Scale, LOT, MHLOC and MA).  
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There was a significant positive correlation 
between QOLIE-31 Total score and 
Item 16 of the BDI-II (r=0.61****) 
 
All three subscales of the QOLIE-10 correlated 
with BDI-II Item 16: 
Epilepsy effect (r= 0.33****) 
Mental health function (r=0.69****)  








































(Enter Method  
 
 
In the group of patients with persisting PNES, 
QOLIE-31 was not correlated with frequency 
of attacks (r=-0.27 ns) 
 
QOLIE-31 score at follow-up was associated 
with: 
Presence of PNES (β = -2.23*) 
depressive symptoms (β = -0.09***) 
economic activity (β = 1.21*) 



































Notes for Table: ASQ= Attachment Style Questionnaire; BAI= Beck Anxiety Inventory, BDI= Beck Depression Inventory, B-IPQ = Brief 
Illness Perception Questionnaire; BSI-18= Brief Symptom Inventory – 18; CORE-10 = Clinical Outcome in Routine Evaluation, DES= 
Dissociative Experiences Scale;  ESP-25 = Emotional Processing Scale-25; ESS= Epilepsy Stigma Scale, EQ-5D-3L = European Quality of 
Life – 3 Dimensions Scale, GAD-7 = Generalized Anxiety Disorder –7; LOT = Life Orientation Test;  LAEP = Liverpool Adverse Events 
Profile; LSES = Lorig Self-Efficiency Scale;  LSS= Liverpool Stigma Scale, LSSS = Liverpool Seizure Scale – Revised; MHLOC= 
Multidimensional Health Locus of Control; MA = Mutuality Assessment; NDDI-E = neurological disorder depression inventory for 
epilepsy, NEWQOL-6D = quality of life in newly diagnosed epilepsy; PHQ-9 = Patient Health Questionnaire – 9, PAI= Personality 
Assessment InventoryPHQ-15 = Patient Health Questionnaire – 15; PTSD-C = Post-Traumatic Symptoms Checklist; QOLIE-10 = Quality 
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of Life in Epilepsy –10; QOLIE-31 = Quality of Life in Epilepsy, QRI = Quality of Relationships Inventory; SCS-SF = Self compassion scale 
short form;  SF-12 = 12 Item Short Form Health Survey,  SF-36 =36-Item Short Form Health Survey,  TSI -2 = Trauma Symptom Inventory 
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Is seizure frequency associated with QOL in PNES? 
The studies reporting on seizure frequency were generally of moderate quality. There was no 
association found between seizure frequency and QOL (Gagny et al., 2021; Green et al., 2017; 
G. H. Rawlings et al., 2017; Salinsky et al., 2019; Walther et al., 2020). Only one study reported 
a weak correlation between seizure frequency and QOL (Robson et al., 2018). QOL was lower 
in a group of individuals with persisting PNES compared to those with PNES cessation; 
however the quality of this study was impaired due to small sample size.  
 
Are demographic factors associated with QOL in PNES? 
Studies looking at demographic factors were of high quality. Most studies reporting 
relationships between age and QoL reported no effect (G. H. Rawlings et al., 2017; Robson, 
Myers, Pretorius, Lian, & Reuber, 2018; Salinsky et al., 2019). Older age at the time of 
receiving a PNES diagnosis was associated with higher QoL in one study (Boesten et al., 2019), 
but not in two other studies (Gagny et al., 2021; Salinsky et al., 2019). No relationship between 
gender and QoL was reported (Gagny et al., 2021; Rawlings, Brown & Reuber, 2017; Salinsky 
et al., 2019). 
 
Higher IQ on the WAIS-III was associated with better QOL (Gagny et al., 2021). Lower level of 
education was associated with a poorer QOL score in one (Boesten et al., 2019) of three 
studies (Rawlings, Brown & Reuber, 2017; Salinsky et al., 2019). QOL significantly correlated 
with employment status in veterans with PNES (Salinsky et al., 2017) and the wider adult 
population with PNES (Robson et al., 2018; Walther et al., 2020). The ability to drive was 
correlated with QOL but significance did not hold in comparison to anxiety and depression 
which appear to   account for more variance in QOL (Salinsky et al., 2019). 
 
Are psychological factors associates with QOL in PNES? 
Quality of the studies investigating the associations between psychological factors and QOL 
were generally of moderate quality. Large correlations between anxiety and QOL were found 
(Avalos et al., 2020; G. H. Rawlings et al., 2017) and anxiety accounted for a significant 
proportion of the variance in QOL (Avalos et al., 2020; Gagny et al., 2021; Rawlings et al., 
2017). Depression was correlated with QOL (Gagny et al., 2021; Novakova et al., 2015; G. H. 
Rawlings et al., 2017; Salinsky et al., 2019; Walther et al., 2020). Higher depression scores on 
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a range of different self-report measures predicted lower QOL, accounting for between 43% 
and 58% of the variance in QOL scores (Gagny et al., 2021; Salinsky et al., 2018; Walther et al 
2019; Wolf et al., 2015). Depression was the highest predictor of QOL when compared to 
other factors (Salinsky et al., 2018).  
 
Psychological distress, a metric created by adding scores of anxiety and depression measures 
together was correlated with QOL and a significant predictor of QOL, accounting for 25% of 
the variance (Rawlings et al. (2017). The CORE-10, a standardized measure of psychological 
distress was also correlated with QOL (Novakova et al. 2015).  
 
QOL was not significantly associated with alexithymia scores in a regression model (Gagny et 
al., 2021). Alexithymia significantly predicted lower QOL in a sample of participants that 
combined people with epilepsy and people with PNES (Wolf et al., 2015). Illness perceptions 
were significantly correlated with QOL (Novakova et al., 2015; Rawlings et al., 2017) and 
accounted for 23% of the variance in QOL scores (G. H. Rawlings et al., 2017). There was no 
evidence of an association between attachment style and QOL (Green et al., 2017) or self-
compassion and QOL (Clegg et al., 2019). 
 
Dissociative experiences were correlated with QOL (Gagny et al., 2021; Cohen et al., 2014), 
but they were not predictive of QOL in multiple regression analysis (Cohen et al., 2014). In 
regard to these findings, not all individuals with PNES experience dissociative symptoms. 
Within Cohen et al. (2014) only 8 participants scored above the cut-off (>30) indicative of 
dissociative experiences.  The methodological quality of these two studies were low owing to 
sampling and data collection methods.  
 
Somatisation, or the tendency to experience unexplained medical symptoms was correlated 
with QOL and accounted for a significant proportion of variance (Salinsky et al., 2019; Wolf et 
al., 2015). Wolf et al. (2015) reported somatisation to be a mediator between diagnosis (PNES 
vs Epilepsy) and QOL, suggesting a strong effect of somatisation on the QOL of patients with 
PNES compared with patients with epilepsy. This was a study of high quality.  
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A history of emotional abuse was associated with QOL (Gagny et al., 2021). In a comparison 
of people with PNES who reported trauma and those who did not, traumatized participants 
on average scored lower on the QOLIE-31psub scales, indicating poorer QOL compared with 
the non- traumatized group (Boesten et al., 2019).  
 
Poor sleep quality was correlated with lower QOL (Latreille et al., 2018). The quality of this 
study was negatively affected by the outcome measures selected for use. Sleep quality was 
assessed by one question on the BDI-II only. 
 
Are social factors associated with QOL?  
The quality of studies investigating the association of social factors and QOL were of variable 
quality; with several studies being marked down on sample size. Higher ratings of patient and 
carer perceived stigma were correlated with lower QOL, demonstrating medium to large 
correlations (Karakis, Janocko, et al., 2020; Robson et al., 2018).  Higher self-reported 
caregiver burden (Karakis, Morton, et al., 2020) and lower caregiver QOL (Wardrope et al., 
2019) was correlated with lower patient QOL.  
 
Discussion 
A wide range of psychological, demographic, seizure related, and social factors have been 
considered in recent research, and this highlights the complexity in assessing and caring for 
people with PNES. The studies reviewed were generally of good quality however not 
consistent in their use of outcome measures across studies. There were a vast number of 




Seizure frequency was not found to be associated with QOL; none of the studies looked at 
seizure reduction within their samples but associations between the number of seizures and 
QOL at one timepoint were not significant. Previously it has been suggested that for patients 
to benefit from seizure reduction, complete seizure cessation needs to occur. This is 
hypothesised as individuals may experience the negative impact of seizures on day-to-day 
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QOL with a small or large number of seizures. The negative consequences do not diminish 
unless seizures are eradicated completely (W. C. LaFrance, Jr., Syc, LaFrance, & Syc, 2009). 
Anxiety, depression and more generic measures of psychological distress were associated 
with QOL. These psychological factors consistently demonstrate high associations and 
account for a significant amount of the variance within QOL. Although the majority of 
research is conducted within specialist centres high levels of anxiety and depression were also 
demonstrated in samples drawn from online forums. The association with psychological 
distress further indicates why eradication of seizures in and of themselves may not improve 
QOL. Individuals with PNES report high levels of distress (Brown & Reuber, 2016) and it 
appears reducing this stress may have a positive impact on QOL.  
 
Demographic characteristics of age and gender did not show strong evidence for association 
with QOL. There was some evidence for the association between being in education or 
employment and better QOL, even across distinct populations as in veterans and civilians. 
This indicates the potential utility of a multi-professional approach and perhaps indication for 
occupational therapy work from professionals in this population.  
 
Psychological factors dissociation, somatisation, emotional abuse and trauma have been 
given consideration within the literature and the quality of studies was generally high. 
However, there is a paucity of research in these areas to make clinical recommendations and 
again a psychological formulation approach may be of benefit to working with patients in the 
absence of wider recommendations.  
 
Social factors have been indicated to be associated with QOL and the role of carers is 
important within this population. The reviewed literature indicates potential association of 
caregiver burden and carer mental health with QOL in people with PNES. Patient and carer 
perceived stigma may also be associated with patient QOL. Due to the use of correlational 
analyses directionality cannot be determined, however social factors and relationships with 
care givers are likely to be important in the treatment of individuals with PNES. 
 
These results are in line with the results reported by the previous review by Jones et al., 
(2016). There is a variation in study quality reported in the previous review. Jones et al., (2016) 
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noted that none of the studies satisfied all three appraisal quality criteria. The present review 
assessed studies on a wider range of criteria and with a standardized tool. The study quality 
of the present review was generally higher than that of the previous. Jones et al noted an 
average sample of n=45, whereas the average sample size of the 16 studies included in this 
review is n=71, further indicating a potential increase in the predictive power of these studies. 
However, post hoc power calculations have not been calculated within the present review.  
 
This review adds to the understanding of the multitude of factors that can impact on the QOL 
of people with PNES. The results indicate depression and more generally psychological 
distress accounts for a large proportion of the variance within QOL scores. Jones et al reported 
only on correlations between anxiety and QOL, whereas in the present review  anxiety 
accounted for a significant amount of the variance within QOL. Hence, more recent evidence 
indicates the relative importance of both depression and anxiety in the context of other 
factors explored. This can be contrasted with the relative unimportance of seizure frequency 
on QOL in people with PNES. This indicates the importance of identifying and managing 
symptoms of both anxiety and depression in the population.  
 
The present review also highlights the importance of care giver mental health for quality of 
life for people with PNES. Jones et al. (2016) found an influence of family members on patient 
QOL. They found unsupportive family environments characterised by criticism and lack of 
interest correlated with lower QOL. A number of the studies within the present review focus 
on the importance of caregiver QOL and shared experience of stigmatisation on patient QOL. 
These results add an important concept to the literature and can focus future research with 
carers and family members to better understand the shared impact of difficulties on both 
patient and caregiver in a non-blaming atmosphere.    
 
Moving forward from the Jones et al. (2016) there has been a considerable advance in the 
number and quality of studies investigating QOL in PNES. Given the continued identification 
of various factors and evolution of the understanding of PNES it is reasonable to suggest that 
an educated approach that considers the literature base coupled with patient centred care 
and individual psychological formulation is warranted in providing intervention to promote 
wellbeing and QOL in the population.   
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Strengths and Limitations 
This review used a standardised quality appraisal tool and incorporated specific criteria 
relevant to the research, but this does not eliminate subjectivity of the results and possible 
bias. Only two studies were appraised by a second rater, meaning that there may be rater 
bias or unreliability. Furthermore, only one rater screened potential studies which may have 
resulted in missed relevant papers. Data extraction was completed by only one rater and 
therefore there is potential for inaccuracy to be present. The search was limited to English 
language studies however there may be relevant papers from other countries further limiting 
the scope of the results.  
 
Clinical implications and future research 
There is evidence for the importance of assessing QOL as a patient reported outcome 
measure and indication that this should be associated with assessment and management of 
psychological distress as it is a consistent predictor of QOL. Symptoms of anxiety, depression 
and QOL can overlap, which may account for some of the association. Using a patient centred 
approach to identify the most salient symptoms and difficulties within an individual is likely 
to be of benefit. Clinical approaches to improve patient QOL and wellbeing should 
acknowledge the wide range of factors identified within the literature coupled with a 
psychological formulation tailored to the individual. Patients with complex presentations can 
prioritise symptoms and identify goals for therapy within this approach.  
 
Psychological therapies, including psychoeducation and input from the wider MDT is 
indicated in this complex and vulnerable population. Traditionally focus has been placed on 
the impact of trauma and abuse within PNES. While this may remain appropriate for a large 
proportion of individuals there is indication that a range of other factors are associated with 
QOL. Depression and anxiety commonly co-occur with the experience of previous trauma. 
These symptoms can be approached in the early stages or separate to trauma interventions 
and at may be of more relevance to individual who do not consider trauma relevant to their 
presentations of PNES.  
 
There are currently no PNES specific measures of QOL; this creates difficulty in synthesising 
research in the population and means that the currently used tool may lack validity and 
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reliability in this complex population. Development of PNES specific measures would be 
beneficial and this has been noted by previous reviews.  
 
Individuals with PNES and co-occurring epilepsy are largely absent within these studies. This 
group of individuals, although many in number tend to be excluded from cohort studies in an 
effort to boost methodological rigour and reduce heterogeneity of samples. Given that co-
occurring epilepsy and PNES is a common presentation, future research should focus on this 
group to determine if QOL is affected by similar factors. These individuals should not be 
disadvantaged in terms of understanding QOL and clinical benefit from interventions at the 
benefit of other groups.  
 
Conclusion 
Individuals with PNES are likely to benefit from routine screening of anxiety and depression 
and offered suitable treatment in line with national guidance on managing anxiety and 
depression in the wider population, regardless of the setting. Individuals managed primarily 
by community or within GP settings may also benefit from screening and intervention. 
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Chapter 2 Major Research Project 
 
Establishing predictors of quality of life in adults with epilepsy and psychogenic non-
epileptic seizures  
 
 




Plain Language Summary 
 
Title 
Investigating quality of life in adults with epilepsy and psychogenic non-epileptic seizures 
Background  
Psychogenic non-epileptic seizures (PNES) are attacks that disrupt a person’s ability to 
respond and can affect their level of consciousness. PNES are often linked to psychological 
distress and present behaviourally in a similar way to epilepsy but lack the abnormal brain 
activity associated with epilepsy. They are thought to result from an involuntary mechanism 
activated by the brain and body to deal with psychological distress. People with epilepsy and 
people with PNES often face challenges with physical and mental health. Seizures can be 
disruptive, distressing and can cause individuals to lose out on social, educational or work 
opportunities. As a result, many people who have seizures report many aspects of their day 
to day living are affected and they have a poor quality of life (QOL). One way to help people 
with seizures is to try and reduce the number of seizures they experience. This can be through 
use of medication for epileptic seizures or through education and psychological therapy for 
PNES. More recently clinicians have focused on exploring how else to help improve a person’s 
QOL other than seizure reduction.  
 
Aims and Questions 
This study focused on exploring what other things affect QOL in people who experience 
epilepsy and PNES. 
1. Do people with PNES report lower QOL than patients with Epilepsy? 
2. What is associated with a person’s QOL? Specifically, between the relationship with 
psychological distress, cognitive problems (like memory and concentration), sleep 
quality and QOL.  
3. Does QOL improve following specialist input, assessment and diagnosis at the Scottish 
Epilepsy Centre (SEC)? If there is improvement, are changes in other outcomes associated 




Routine data collected from individuals attending the SEC from March 1st 2019 to March 31st 
2020 was analysed. No additional data beyond that already collected by the SEC for clinical 
purposes was collected. Individuals were approached as part of their admission process to 
the SEC. Individuals experiencing seizures and PNES were included in the analysis and formed 
two separate groups. Individuals with a diagnosed cognitive impairment including learning 
disability were excluded.  
 
Main Findings and Conclusions 
People with PNES or epilepsy rated themselves as having difficulties in QoL on a day to day 
basis and there was no difference in the QOL scores between the two groups. The level of 
psychological distress in people with epilepsy and PNES predicts how good a person’s QOL is. 
People with high levels of psychological distress (anxiety and depression) have a lower QOL 
and those with lower levels of psychological distress have higher QOL. People with PNES and 
people with epilepsy report that their sleep quality is poor. It appears that sleep quality is 
linked to QOL in people with epilepsy but not for those with PNES. Cognition scores appear 
to predict QOL in people with PNES but not people with epilepsy.   
 
It appears that reducing anxiety and depression or psychological distress is likely to have a 
positive impact on QOL for both groups of individuals. The evidence regarding the importance 
of sleep and cognition on QOL is limited within this study although further research may help 
indicate if these factors are important across both groups. Of course, if individuals feel that 
any of the above factors are having an impact on their QOL it is important to address this with 





This longitudinal study examined QOL in individuals with psychogenic non-epileptic seizures 
(PNES) and epilepsy and investigated factors associated with QOL and change in QOL from 
admission to discharge at a specialist epilepsy centre.   
Methods 
Fifty-five patients with epilepsy and 23 patients with PNES who attended the William Quarrier 
Scottish Epilepsy Centre (SEC) between March 1st 2019 and March 31st 2020 were included.  
Participants completed self-report measures in the week prior to or on the day of their 
admission to the SEC and again on the day of discharge.  
 
Results 
There was no significant difference between QOL scores in the PNES and epilepsy groups. 
Psychological distress at admission was found to be a significant predictor of QOL scores (at 
admission). In the epilepsy group, psychological distress accounted for 37.1% of the variance 
in QOLIE-31 admission scores in model one (p<.0001). Sleep Condition Indicator scores (SCI) 
(p=.001) and cognition scores as measured by the EpiTrack cognitive assessment (p=.167) 
accounted for a further 16.9% of the variance (p=.003) in model two. EpiTrack scores did not 
contribute significantly to the variance associated with QOLIE-31 scores. In the PNES group 
psychological distress accounted for 30.5% of the variance in QOLIE-31 admission scores in 
model one (p=.014). SCI (p=.605) and EpiTrack scores (p=.003) accounted for a further 31.5% 
of the variance in model two (p=.011). SCI scores did not contribute significantly to the 
variance associated with QOLIE-31.  
 
QOL was improved at discharge in the PNES group (t(17) = -4.187; p=0.001), psychological 
distress change scores accounted for 56.6% of the variance in QOLIE-31 change  scores in 
model one (p <.0001). QOL was also improved at discharge in the epilepsy group (t(35) = -
5.875, P=0.001), psychological distress change scores accounted for 59.4% of the variance in 
QOLIE-31 change  scores in model one. In model two of both groups, the SCI scores and 




Psychological distress is a good predictor of QOL in both patient groups. Assessment and 
management of anxiety and depression symptoms in both groups may enhance QOL. SCI 
scores made a significant contribution to the variance in QOL in the epilepsy group and 
EpiTrack Scores made a significant contribution to the QOL scores in the PNES group. Future 
research may examine the effect of sleep strategies on QOL scores and study the effect of 
change in cognitive scores following AED reduction on QOL.  
 




Individuals with epilepsy and psychogenic non epileptic seizures (PNES) have been shown to 
have reduced QOL compared to other clinical populations (Al Marzooqi et al., 2004). 
Individuals with PNES consistently report poorer quality of life than individuals with epilepsy 
(Myers et al., 2012; Szaflarski, Szaflarski, et al., 2003; Testa et al., 2007). Patients with PNES 
have high levels of disability (Jennum, Ibsen, & Kjellberg, 2019) and outcomes in this group 
are relatively poor (S. G. Jones et al., 2010; Markus Reuber et al., 2003).  
 
Studies on clinical outcomes in people with PNES and people with epilepsy have focused on 
reducing seizure frequency and severity. More recently there has been recognition of the 
impact of complex physical and mental health comorbidities and wider social/socio-economic 
factors and their impact on individuals.  There have been a wide range of factors studied in 
attempts to determine the most significant associates of QOL in people with PNES.  
 
Chapter one of this thesis, a systematic review found that seizure frequency was not 
associated with QOL. Anxiety, depression and psychological distress were associated with 
QOL and consistently account for a significant amount of the variance within QOL within the 
literature. The majority of research reviewed was conducted within specialist centres, 
however high levels of anxiety and depression were also demonstrated in samples drawn 
from online forums. This research suggests the importance of identifying psychological 
distress in individuals with PNES. 
 
Other clinical factors, such as difficulty achieving correct diagnosis may impact on QOL.  
Difficulties in distinguishing between epilepsy and PNES outside of dedicated facilities can 
result in the misdiagnosis of PNES as epilepsy and individuals can wait an average of 7 years 
before receiving the correct diagnosis (M. Reuber, Fernández, Bauer, Helmstaedter, & Elger, 
2002). At the point of correct diagnosis individuals and those in their social networks including 
families, friends, teachers or colleagues may have experienced years of conceptualising their 
symptoms as epilepsy resulting from brain abnormalities. Some patients can be reluctant to 
accept the diagnosis of PNES and view it as invalidating or confusing (Stone et al., 2003; 
Thompson, Isaac, Rowse, Tooth, & Reuber, 2009). Inappropriate treatment with anti epileptic 
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medication can produce unwanted side effects whilst having no clinical value in reducing 
PNES (S. G. Jones et al., 2010). 
 
High levels of psychiatric comorbidity including depression, anxiety, post-traumatic stress and 
personality disorders are common in people with PNES   and typically at a level greater than 
that of individuals with epilepsy and those in the general population (Diprose, Sundram, & 
Menkes, 2016). A systematic review by B. Jones, Reuber, and Norman (2016b) investigated 
correlates of QOL in individuals with PNES. Depressive symptoms correlated most highly. They 
also found that dissociation, somatic symptoms, escape‐avoidance coping strategies, and 
family dysfunction were associated with QOL. Interestingly there was little support for an 
association between QOL, seizure frequency, and demographic factors. Johnstone, Malpas, 
Velakoulis, Kwan, and O'Brien (2021) report that psychiatric symptoms, depression and 
cognition were greater determinants of QOL than seizure frequency in people with PNES.  
 
Cognitive impairment has been associated with reduced QOL in people with epilepsy 
(Giovagnoli & Avanzini, 2000; Giovagnoli et al., 2014) and whilst cognitive complaints are 
common in people with PNES,  there is variability in research findings from studies 
investigating objective cognitive deficit in PNES (Willment, Hill, Baslet, & Loring, 2015). 
Cognitive impairment can be cause by a number of factors including structural abnormalities 
and neurodegenerative causes, psychiatric comorbidity (most notably depression) or sleep 
difficulties amongst others.  
 
Sleep disturbance in people with PNES has been noted both subjectively by patient report 
measures and there is emerging evidence that sleep architecture may be altered in people 
with PNES (Vanek et al., 2021). Previous research on the association between self-reported 
sleep scores and QOL is sparse but one recent study in a small sample of people with PNES 
(n=15) found no direct correlation between sleep scores and QOL (Erickson et al., 2019). QOL 
in people with PNES may be increased by making improvements to sleep hygiene and 
treatment of sleep difficulties in this group. 
 
A recent review by Asadi-Pooya et al. (2021) reported on the importance of attachments, 
marriage, social networking, stigma and education or employment in determining the QOL of 
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people with PNES . Individuals with PNES in Scotland have previously been reported to 
experience high levels of multiple deprivation (Duncan, Oto, & Wainman-Lefley, 2012). It is 
possible that living in circumstances with high deprivation has a negative effect on the 
symptoms of PNES, mental health and social supports. 
 
Present Study 
This project assesses associations between QOL and psychological symptoms, sleep quality 
and cognition in individuals with PNES or epilepsy using routine outcome data from inpatient 
admissions to the William Quarrier Scottish Epilepsy Centre (SEC). Various terms are used to 
describe seizure episodes not caused by abnormal brain activity. “Psychogenic Non-Epileptic 
Seizures” was used within the present study in correspondence with the terminology of the 
service where the study took place.  
 
Research Questions: 
1. Do patients with PNES report lower QOL than patients with Epilepsy? 
2. What factors are associated with QOL? Do psychological, cognitive or sleep condition 
measures predict QOL? 
3. Does patient reported QOL improve following specialist input, assessment and 
diagnosis? 
4. If improvement in QOL does occur during admission, are changes in other outcomes 




A retrospective cohort study, using routinely collected data from inpatients attending the SEC.  
 
Ethical Approval 
Research and Innovation approval for the study was granted by NHS Greater Glasgow & Clyde 
Health Board (GN20NE586, Appendix 2.1). Ethical approval was granted by the SEC 
Governance Committee (Appendix 2.2). NHS Scotland Research Ethics committee advised 
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application was not necessary as data were collected as part of routine processes within the 
SEC and were anonymised prior to being supplied to the researcher (Appendix 2.3).  The 
University of Glasgow Medical, Veterinary and Life Sciences Ethics committee advised Ethical 
approval granted by the SEC was sufficient and duplication not required (Appendix 2.4).   
 
Recruitment  
Patients attending the SEC are routinely asked for their data to be used for research and/or 
audit on admission. Data on consecutive patients who consented and were routinely 
admitted to the SEC between 1st of March 2019 to 31st March 2020 was analysed.  
 
Setting  
The SEC is a national epilepsy monitoring unit for Scotland, located in Glasgow. Individuals 
are typically referred by the NHS to the SEC in order to: clarify diagnosis and understand the 
nature of seizures; record physiological and behavioural data during seizures; assess how 
seizures affect health and life; assess how factors in an individual’s life influence their seizures 
and health; assess if seizures and illness affect an individual’s mood and memory; make 
changes to treatment and medications and/or receive individual advice and support to help 
individuals live with epilepsy and PNES. Professionals within the centre endeavour to provide 
a concrete diagnosis, however due to the inherent difficulty in differentiating between PNES 
and epilepsy, some individuals may be discharged with an “uncertain” diagnosis. 
 
Participants 
Patients are referred from all over Scotland and some from Northern Ireland. Typically, 
individuals are admitted for 4 weeks, but stays from between 2 and 6 weeks are not 
uncommon. 
 
Inclusion Criteria: Participants were adult inpatients (aged 16 and over), with a confirmed 
diagnosis of epilepsy or PNES at the time of discharge from the SEC, and fluent in English. 
Exclusion Criteria: Patients who did not give consent for data to be used or those with a known 
moderate to severe cognitive impairment, including if resulting from learning disability or 
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acquired brain injury were excluded. Participants with co-occurring PNES and Epilepsy or 
those with uncertain diagnosis at discharge were excluded.  
 
Diagnosis 
The discharge diagnosis was made by the lead Consultant Neurologist, Neuropsychiatrist or 
Neurophysiologist within the SEC, involved in the patients’ care. Diagnosis was based on 
Video Electroencephalography (EEG) monitoring in most cases. If no episodes were captured 
during admission, diagnosis was based on prior eyewitness description of typical events, or 
from video footage of typical events. Diagnoses were: “Epilepsy”, “PNES”, “Co-occurring PNES 
and Epilepsy” or “Unclear Diagnosis”. “Unclear Diagnosis” included those with uncertainty 
within their presentation. For example, those with a confirmed diagnosis of Epilepsy but 
diagnostic uncertainty about the presence of co-occurring PNES or vice-versa.  
Outcome Measures 
Outcome measures were administered at admission and discharge. Participants were sent 
self-report measures prior to admission and asked to complete them in the week leading up 
to admission. In some cases, patients completed the measures during the first few days of 
admission. Cognitive screens were completed at both time points by a clinical psychologist or 
senior nurses under the supervision of a clinical psychologist. 
 
Quality of Life 
Quality of Life in Epilepsy (QOLIE-10/10-P/31/89; (Cramer et al., 1998)): The most commonly 
used tool in studies on prediction of QOL in patients with PNES (B. Jones et al., 2016b). The 
QOLIE-31 comprises 31 items rated on various Likert scales. The questionnaire asks patients 
to estimate quality of life and how they feel. It measures QOL across the domains of seizure 
worry, overall quality of life, emotional well-being, fatigue, cognition, medication effects, and 
social functioning. A weighted total QOL score is generated, and higher scores represent 
better QOL. The QOLIE-31 has high reliability and validity among adults with confirmed 
epilepsy (Devinsky et al., 1995). When used with participants with PNES the questionnaire is 
adapted by changing “Epilepsy” to “Seizures”. Saadi, Patenaude, and Mateen (2016) 




Generalized Anxiety Disorder- 7 (GAD-7, (Spitzer, Kroenke, Williams, & Löwe, 2006)): This 
widely used screening tool for anxiety comprises 7 items with responses rated on a four-item 
Likert scale. Scores 5-9, 10-14 and 15 or over indicate mild, moderate and severe anxiety, 
respectively. The measure asks participants to consider how often they have been bothered 
by anxiety-related problems over the past two weeks. The GAD-7 has been validated in French 
patients with epilepsy and comorbid GAD and has satisfactory internal consistency 
(Cronbach’s alpha=0.89, Micoulaud-Franchi et al., 2016). It has been used in patients with 
PNES (Chen et al., 2014). In primary care populations it has good psychometric properties 
(Cronbach’s alpha=0.92; (Kroenke, Spitzer, Williams, Monahan, & Löwe, 2007)). 
 
Depression 
Neurological Disorders Depression Inventory for Epilepsy (NDDI-E): This screening tool for 
major depression comprises 6 items, with responses rated on a four-point scale. Higher scores 
indicate a greater number of depressive symptoms. The NDDI-E is validated in patients with 
epilepsy and has satisfactory internal consistency (Cronbach’s alpha=0.82, (Gilliam et al., 
2006)).  For a UK population the ideal cut-off is >15, resulting in 87% specificity and 81% 
sensitivity against DSM-IV major depression (Mula et al., 2016). Factor analysis of French 
patients with Epilepsy showed that the GAD-7 and the NDDI-E provide complementary 
information (Micoulaud-Franchi et al., 2016), and these authors recommend the routine use 
of both GAD-7 and NDDI-E in the clinical evaluation of patients with epilepsy. 
 
Sleep Quality 
Sleep Condition Indicator (SCI; Espie et al. (2014)):  This eight-item screening measure for 
insomnia covers concerns about getting to sleep, remaining asleep, sleep quality, daytime 
personal functioning, daytime performance, duration of sleep problem, nights per week 
having a sleep problem, and extent troubled by poor sleep. Items are scored on a 5-point 
scale, with higher scores indicative of better sleep. Scores ≤ 16 are indicative of probable 






EpiTrack (Lutz & Helmstaedter, 2005): This brief screening tool assesses effects of antiepileptic 
drugs (AEDs) on cognition. It has been validated in patients with epilepsy but is relevant for 
patients with PNES who frequently prescribed AEDs prior to PNES diagnosis are. It includes 
six subtests assessing attention, cognitive tracking, and working memory via the Trail-Making 
Test (parts A and B), a test of response inhibition and motor speed, digit span backwards, 
written word fluency, and a maze test. EpiTrack subtest scores range from 1 to 7, with lower 
scores indicating poorer performance. EpiTrack total scores ≥29 indicate unimpaired 
performance, 26-28 are borderline and ≤25, impaired cognitive performance. The EpiTrack 
has satisfactory internal consistency (Cronbach’s α = 0.750) in “normal” adults. The tool has 
built in scoring structure to control for the effect of age on cognitive functioning.  
 
Deprivation 
Scottish Index of Multiple Deprivation (SIMD, 2020). This is a national statistics publication 
for Scotland. It ranks 6,976 geographical areas within Scotland on the basis of postcode. Ranks 
take into account income, employment, education, health, access to services, crime and 
housing. Ranks can be divided into vigintiles with 1, the most deprived and 20, the least 
deprived (SIMD Results, Scottish Government 2020).  
 
Power and Sample Size 
W. Curt LaFrance, Jr. et al. (2011) and Karakis et al. (2014) found large effect sizes when 
comparing QOLIE-31 scores with the Beck Depression Inventory (r=-0.73 and r=-0.77 
respectively). Large correlations have been demonstrated between QOLIE-31 and the Beck 
Anxiety Inventory (BAI) (r= -0.66; (Karakis et al., 2014). Using G*Power (Faul, Erdfelder, 
Buchner, & Lang, 2009) it is estimated that n=13 is required to detect a large effect (r= 0.70) 
with 80% power, α = 0.05, using correlation, two-tailed. To detect a medium effect (r=0.40) 
with 80% power and α = 0.05, an n of 46 is needed again using two-tailed correlation. 
 
Previous research using multiple linear regression analysis of QOLIE-31 scores with BDI as a 
predictor produced r² = 0.58 (Mitchell, Ali, & Cavanna, 2012) and multiple linear regression of 
QOLIE-31 scores with self-report of anxiety from the Hospital Anxiety and Depression Scale 
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as a predictor, demonstrated, r² = 0.40 (Avalos et al., 2020). Using G*Power (Faul et al., 2009) 
a sample size of 30 participants would be required to detect a large effect (f²=0.66), with 
power of 80%, α= 0.05 using multiple linear regression (r²-deviation from zero) with seven 
predictor variables specified. To detect a medium effect (f²=0.31), α= 0.05, in a model with 
seven predictor variables, n=54 would be required. All potential participants (n=144) were 
considered because there could be many exclusions due to co-occurring diagnoses, learning 
disability and missing data. A minimum of 50 participants in each group was aimed for.  
 
Statistical Analysis Plan 
Data were analysed using IBM SPSS Statistics version 27 for Microsoft Windows. Pairwise 
deletion of missing data was employed throughout. Variables were checked for normality 
using the Kolmogorov-Smirnov (K-S) test. The significance level p<0.05 was used across all 
analyses., Corrections for multiple comparisons of t-tests and correlation analyses were not 
applied. This decision was taken as the outcome variables from the SCI and EpiTrack scores 
have not been investigated extensively in previous literature and can be viewed here as 
exploratory analysis. Interpretation is carried out with caution in light of this.   
 
Differences between groups 
Independent samples t-tests, Mann-Whitney U and Chi-Square test were employed to check 
for differences in demographic information and outcome measures of the two groups.  
 
Correlation between QOLIE-31 admission scores and outcome measures 
Correlation analysis was conducted separately for the epilepsy and PNES groups. Pearson 
Product Moment correlations (r) were used for normally distributed data and Spearman Rank 
correlations (rs ) were used for data with non-normal distribution.  
Hierarchical Multiple Regression of QOLIE-31 admission scores with correlated outcome 
measures as independent variables.  
Only variables that were significantly correlated (p<0.05) with QOLIE-31 admission scores 
were entered into the regression.  In accordance with previous studies investigating the 
predictive value of social, psychological and clinical factors on QOL, psychological outcome 
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measures (anxiety and depression) were entered before cognitive and sleep measures, using 
the enter method.   (G. H. Rawlings et al., 2017; Rizou, De Gucht, Papavasiliou, & Maes, 2015).  
 
Change in QOLIE-31 and other outcome measures from admission to discharge 
Within samples t-tests and Wilcoxon Signed Rank tests were used to measure change across 
admission.  
 
Regression of change in QOLIE-31 scores 
A new variable “QOLIE-31 Change Score” (QOLCS) was calculated by subtracting QOLIE-31 
admission scores from QOLIE-31 discharge scores for each participant. This method was used 
to create Change Scores (CS) for each of the outcome measures. Normality of these variables 
was assessed as per the above protocol and K-S testing. Pearson and Spearman correlations 
were used to examine associations between the QOL-CS and GAD-7-CS, NDDI-E-CS, SCI-CS and 
EpiTrack-CS. Hierarchical multiple regression was conducted with QOL-CS as the dependent 
variable and any significantly correlated outcome measures entered into the model as per the 
previous method.  
 
Data Screening 
The data set provided by the SEC consisted of 144 participants, the following participants 
were excluded from analysis: 24 participants with learning disability, one participant 
discharged before diagnosis, two participants whose primary diagnosis was not epilepsy or 
PNES, nine participants who did not complete outcome measures, 16 participants diagnosed 
with co-occurring epilepsy and PNES and 14 participants with no final diagnosis at discharge. 
Of the 78 remaining participants included in the analysis, 55 (70%) had a discharge diagnosis 
of epilepsy and 23 (29%) had a discharge diagnosis of PNES. 
 
Results 
Missing values throughout the dataset resulted in varying numbers across the statistical 
analyses; n values are reported within all accompanying tables.  The smallest sample size 
available within the analyses of the PNES group was 18 and the largest was 23, in the epilepsy 
group the smallest was 43 and the largest was 55. 
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Kolmogorov-Smirnov analysis indicated that several variables, were not normally distributed. 
In the epilepsy group these were Length of Admission, age, NDDI-E discharge, GAD-7 
(admission and discharge), EpiTrack (admission and discharge), QOL-CS, NDDI-E-CS and 
EpiTrack-CS. In the PNES group these were SIMD, EpiTrack Discharge, NDDI-E-CS, SCI-CS and 
EpiTrack-CS. (see Appendix 2.5).  
 
Age, gender and SIMD were not included in the regression model because they did not 
significantly correlate with QOLIE-31 (in either diagnostic group). GAD-7 and NDDI-E were 
entered in step one of the regressions followed by SCI and EpiTrack scores at step two. GAD-
7 and NDDI-E admission scores were highly correlated in both epilepsy (rho = .658, p= 
0.0000001) and PNES (r = .525, p=0.01) groups and results from multicollinearity diagnostics 
of the regression model (Appendix 2.6) indicated collinearity of GAD-7 and NDDI-E, in both 
groups. In line with previous research a new variable termed “Psychological Distress” (PD) 
was created by combining the scores of these two measures (Rawlings & Reuber, 2017).  The 
equation used in the present study was PD Admission = (z-scores NDDI-E admission + z-scores 
GAD-7 admission) and PD Discharge = (z-scores NDDI-E discharge + z-scores GAD-7 discharge). 
Psychological distress was then employed as an independent variable within the regression 
of QOL for both groups and results displayed within the results section. Results for the 
regression using GAD-7 and NDDI-E can be found in Appendix 2.7. 
 
Demographics in PNES vs. Epilepsy Groups 
The demographic and psychological profile of participants with epilepsy and PNES are shown 
in Table 1. There were no significant differences between groups in age, gender or length of 
admission. SIMD vigintile scores were lower in the PNES group (median 2) than in the epilepsy 
group (median 8), (U=292.00, p=0.002; effect size r = 0.36).  This indicates participants in the 
PNES group were living in more deprived areas of Scotland. The SIMD vigintile of 2 is in the 
6th to 10th percentiles of Scotland’s data zones while the epilepsy group (Vigintile 8) were 





Research Question 1. Do PNES and Epilepsy groups differ on QOL or other outcome measures? 
QOL scores in the PNES (M= 31.11, SD= 12.47) and the epilepsy groups (M=32, SD= 14.87) 
were not significantly different (p=.807).  GAD-7 scores in the PNES (Median=15) and epilepsy 
groups (Median=16) indicate severe anxiety and mean NDDI-E scores indicate major 
depression (PNES, M= 18; epilepsy, M=17). Both groups scored within the range of probable 
insomnia on the SCI (PNES, Median= 11; epilepsy, Median=15). PNES scores on the EpiTrack 
were within the unimpaired range (Median= 29) and in the impaired range in the epilepsy 
group (Median=27) at admission, indicating a clinical difference. 
 
At admission, there was no significant difference between any of the outcome variables in 
the two groups (p>0.05, Table 1). Levene’s test showed that the variances for SCI scores at 
admission were not equal and did not meet the assumption of homogeneity of variance. 
Analysis for SCI was therefore conducted with a non-parametric Mann-Whitney U test.  
 
Table 1. Differences in demographic and psychological variables (at admission) between 
groups, Mean (SD) or Median (IQR)1 and [N]. 
 Epilepsy [55] PNES [23] P 
value 
Test statistic  
Demographic Variables     
Female 67% [37] 44% [10] 0.05 3.83 (Chi-Square) 
Age (years)1 37 (27-45) [55] 40 (26-52) [23] 0.41 707 (MWU) 
SIMD Vigintile Score1 8 (3-11) [52] 2 (1-6) [21] 0.002 292 (MWU) 
Admission Length 
(days)1 
21 (14-28) [55] 21 (14-28) [23] 0.93 625 (MWU) 
Psychological Variables 
(at admission) 
    
QOLIE-31  32 (14.87) [50] 31 (12.47) [22] 0.81 2.45 (T-Test) 
GAD-71 15 (10-19) [52] 16 (9-18) [23] 0.78 573 (MWU) 
NDDI-E 18 (3.94) [52] 17 (4.26) [23] 0.49 0.69 (T-Test) 
EpiTrack1 27 (19.75-33.25) [46] 29 (26-34) [20] 0.18 555.50 (MWU) 
SCI1 15 (7.25-22.75) [52] 11 (7-15) [23] 0.07 443 (MWU) 
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PNES=Psychogenic non-epileptic seizures, SIMD=Scottish index of Multiple deprivation, QOLIE-31=Quality of life 
in epilepsy-31, GAD-7=Generalised anxiety disorder – 7, NDDI-E=Neurological Disorders Depression Inventory, 
SCI=Sleep condition index, MWU= Mann Whitney U 
 
 
Research Question 2. What factors are associated with QOL?  
Age and SIMD scores were not significantly associated with QOL in either group (table 2). 
Gender was not significantly associated with QOLIE-31 scores in the epilepsy group as 
indicated by the QOLIE-31 scores of males (M=31.44, SD = 16.53)  and females (M=32.26, SD 
= 14.30)  in the epilepsy group t(48)=-.18, p=.858. In the PNES group the QOLIE-31 scores of 
males (M=26.11, SD = 9.75) was significantly lower than females (M=37.11, SD = 13.15)  , 
t(20)=-2.251, p=.04. 
 
Higher anxiety on the GAD-7 (p <.0001), higher depression on the NDDI-E (p<.0001)  and 
higher insomnia on the SCI (p<.0001) was associated with lower QOL in the epilepsy group 
with large effect sizes. In the PNES group higher anxiety scores on the GAD-7 (p=.007) were 
associated with lower QOL scores and higher cognitive scores on the EpiTrack (p=.003) were 
associated with higher QOL scores, both with large effect sizes (table 2). 
 
Table 2. Correlations between QOLIE-31 scores and outcome measures at admission in 
epilepsy and PNES groups [N]. 
 
Age SIMD  NDDI-E GAD-7 EpiTrack SCI 
Epilepsy Group  
    












 [50] [47] [50] [50] [42] [50] 
PNES Group      












 [22] [20] [20] [22] [19] [22] 
1Spearman Correlation;  2Pearson Correlation, PNES=Psychogenic non-epileptic seizures, SIMD=Scottish index of 
Multiple deprivation, QOLIE-31=Quality of life in epilepsy-31, GAD-7=Generalised anxiety disorder – 7, NDDI-E= 




Do psychological, cognitive or sleep condition measures predict QOL in PNES or Epilepsy 
groups? 
A linear regression with QOLIE-31 admission scores as dependent variable, and psychological 
distress, SCI and EpiTrack scores as dependent variables was conducted. The regression model 
met assumptions for multiple linear regression (appendix 2.8). In the epilepsy group, 
psychological distress accounted for 37.1% of the variance in QOLIE-31 admission scores in 
model one (unadjusted r², p<.0001). Together SCI (β =.395, p=.001) and EpiTrack (β =.156, 
p=.167) scores accounted for a further 16.9% of the variance (unadjusted r², p=.003) in model 
two. EpiTrack scores did not contribute significantly to the variance associated with QOL. The 
final model accounted for 54% of the variance in QOLIE-31 scores (unadjusted r², p<.0001). 
 
In the PNES group psychological distress accounted for 30.5% of the variance in QOLIE-31 
admission scores in model one (unadjusted r², p=.014). SCI (standardised β = -.126, p=.605) 
and EpiTrack scores (standardised β = .575, p=.003) accounted for a further 31.5% of the 
variance in model two (unadjusted r², p=.011). SCI scores did not contribute significantly to 
the variance associated with QOL. The final model accounted for 62% of the variance 
(unadjusted r², p=.002) in QOLIE-31 scores (Table 3). 
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Table 3. Summary of hierarchical multiple regression analysis for variables predicting QOLIE-31 admission scores in Epilepsy or PNES groups.  
PD=Psychological Distress, PNES=Psychogenic non-epileptic seizures, SIMD=Scottish index of Multiple deprivation, QOLIE-31=Quality of life in epilepsy-31, GAD-
7=Generalised anxiety disorder – 7, NDDI-E=Neurological Disorders Depression Inventory, SCI=Sleep condition index 
Discharge 
Diagnosis 
N R R² Adjusted 
R² 













Model 1   .609 .371 .355 23.596 <.0001 .371 23.596 <.0001 32.344 (28.615 – 36.072)  <.0001 
PD 52 
   
     -4.884 (-6.916 – -2.852) -.609 < .0001 
             
Model 2   .735 .540 .504 14.863 <.0001 .169 6.973 .003 15.005 (2.109 – 28.001)  .024 
PD 52 
   
     -4.223 (-6.069 – -2.377) -0.527 < .0001 
EpiTrack 46 
        
.293 (-.129 – .721) .156 .167 
SCI 52 
        
.624 (.261 – .986) .395 .001 
              
PNES 
Group 
Model 1   .553 .305 .264 7.472 .014 .305 7.427 .014 30.489 (25.292 – 35.685)  <.0001 
PD 21         -3.784 (-6.704 – -.863) -.553 .014 
             
Model 2   .787 .620 .544 8.161 .002 .315 6.214 .011 -4.570 (-28.847 – 19.707)  .694 
PD 21         -3.880 (-7.318 – -.443) -.567 .029 
EpiTrack 20         1.298 (.513 – 2.084) .575 .003 
SCI 23         -.267 (-1.347 – .813) -.126 .605 
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Research Question 3. Does patient reported QOL improve following specialist input, 
assessment and diagnosis? 
 PNES group:  Mean QOLIE-31  scores were higher at discharge with a large effect size (t(17) 
= -4.187; p=0.001). Mean GAD-7 (t(19) = 2.415, p=0.026) and NDDI-E (t(18) = 1.968, p=0.064) 
were  lower at discharge, showing moderate effect sizes. SCI (t(19) = -.754, p=.460) and 
EpiTrack (z= -1.286, p=.199) scores were higher at discharge showing small effect sizes but 
were not statistically significant (table 4). 
 
Table 4. Comparison of admission and discharge scores within the PNES Group, Mean (SD) or 
Median (IQR)1 [N] and Cohen’s D effect size. 
 Admission Scores Discharge Scores p-VALUE  Effect Size 
QOLIE-31 [18] 33.09 (12.44)  50.83 (19.94) <.001 .99 
NDDI-E [19] 17.32 (4.41) 14.53 (4.16) .06 .45 
GAD-7 [20] 13.45 (5.72)   9.40 (6.46) .03 .54 
SCI1 [20] 11 (7-15) 13 (10-19.50) .46 .17 
EpiTrack1 [19] 29.50 (26 - 34) 34.00 (30 -35) .20 .30 
QOLIE-31=Quality of life in epilepsy-31, GAD-7=Generalised anxiety disorder – 7, NDDI-E=Neurological 
Disorders Depression Inventory, SCI=Sleep condition index 
 
Epilepsy group:  QOLIE-31 (t(35) = -5.875, P=0.001), EpiTrack (z= -3.44, p<0.001) and SCI scores 
(t(42) = -2.930, p 0.01, ) were significantly higher at discharge.  NDDI-E (z=-4.80, p< 0.00001) 
and GAD-7 (z= -4.80, p<0.00001) scores were significantly lower at discharge (Table 5). Effect 
sizes were moderate to large throughout. Graphical representations of the changes in scores 










Table 5. Comparison of admission and discharge scores within the Epilepsy Group, Mean (SD) 
or Median (IQR)1 [N] and Cohen’s D effect size. 
 Admission Scores Discharge Scores p-value  Effect Size 
QOLIE-31 [36] 29.53 (14.93) 49.11 (19.87) <.001 .98 
NDDI-E1 [45] 18 (16 - 21.75) 15 (10 - 18) <.001 .72 
GAD-71 [45] 15 (10 - 19)   8 (3-15) <.001 .72 
SCI1 [43] 15.00 (7.25-22.75) 18.50 (11.25-25.75) .005 .45 
EpiTrack1 [39] 27.50 (19.75 - 33.25) 29 (22.5 - 34) <.001 .55 
QOLIE-31= Quality of life in epilepsy-31, GAD-7= Generalised anxiety disorder – 7, NDDI-E= Neurological Disorders 
Depression Inventory, SCI= Sleep condition index 
 
Research Question 4.  If improvement in QOL does occur during admission, are changes in 
other outcomes associated with that improvement? Can QOL improvement be predicted by 
other factors? 
A linear regression of QOLIE-31 scores was carried out with psychological distress change 
scores in model one and SCI and EpiTrack change scores added in model two (enter method). 
The regression met the assumptions for multiple linear regression. In the epilepsy group, 
psychological distress change scores accounted for 59.4% (unadjusted r²) of the variance in 
QOLIE-31 change scores in model one. The final model accounted for 60.2% (unadjusted r²) 
of the variance in QOLIE-31 change scores, however the change in model two was not 
significant (p=.77) the SCI scores (standardised β = .097, p=.479) and EpiTrack scores 
(standardised β = -.022, p=.865) did not contribute significantly to the variance associated 
with QOL change scores.  
 
In the PNES group psychological distress change scores accounted for 56.6% of the variance 
in QOLIE-31 change scores in model one (unadjusted r², p <.0001). The final model accounted 
for 57.7% of the variance in QOLIE-31 change scores, however the change in model two was 
not significant (unadjusted r², p=.845) the SCI change scores (Standardised β = -.044, p=.865) 
and EpiTrack change scores (standardised β = .123, p=.70) did not contribute significantly to 




What variables are associated with QOL discharge scores? 
An additional linear regression was conducted to examine the predictive value of SCI and 
EpiTrack discharge scores on QOL scores at discharge. QOL at discharge was entered as the 
dependent variable, with psychological distress, SCI and EpiTrack discharge scores as the 
independent variables. The same protocol was used as in the previous regression analyses. 
Psychological distress score at discharge accounts for a significant proportion of the variance 
in QOL in model one of the epilepsy group (t(30) = -7.079, p<.0001) and model one of the 
PNES group (t(16) = -5.480, p<.0001). In the epilepsy group EpiTrack (Standardised β = .079, 
p=.498) and SCI (standardised β =.156, p=.222) did not significantly contribute to variance 
associated with QOL scores. In the PNES group the SCI (standardised β =.462, p=.008) scores 
contributed significantly to the variance associated with QOL scores in model 2, but EpiTrack 
(standardised β =.189, p=.177) scores did not (table 7) 
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Table 6. Summary of hierarchical multiple regression analysis for variables predicting change in QOLIE-31 scores between admission and  
discharge in Epilepsy or PNES groups 
 






n R R² Adjusted 
R² 












Model 1   .771 .594 .579 39.449 <.0001 .594 39.449 <.0001 17.528 (12.538 – 22.518)  <.0001 
PD-CS 36         -7.939 (-10.532 – 5.345) -.771 <.0001 
             
Model 2   .776 .602 .55 
 
12.607 <.0001 .008 .263 .77 16.993 (10.774 – 23.213)  <.0001 
PD-CS 36         -7.587 (-10.449 – -4.724) -.736 <.0001 
EpiTrack-CS 39         -.121 (-1.569 – 1.327) -.022 .865 
SCI-CS 43         .213 (-.397 – .823) .097 .479 
              
PNES 
Group 
Model 1   .752 .566 .537 19.528 <.0001 .566 19.528 <.0001 20.437 (13.978 – 26.895)  <.0001 
PD-CS 18         -5.379 (-7.973 – -2.784) -.752 <.001 
             
Model 2   .759 .577 .479 5.903 .009 .011 .171 .845 19.722 (11.655 – 27.788)  <.001 
PD-CS 18         -5.177 (-9.133 – -1.221) -.724 .014 
EpiTrack-CS 19         .444 (-1.202 – 2.091) .123 .70 
SCI-CS 20         -.090 (-1.207 – 1.027) -.044 .865 
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Table 7. Summary of hierarchical multiple regression analysis for variables predicting QOLIE-31 discharge scores Epilepsy or PNES groups 
 
 
PD -CS=Psychological Distress Change Score, EpiTrack -CS=EpiTrack Change Score, SCI-CS=Sleep Condition Indicator Change Score, PNES=Psychogenic non-epileptic seizures 
Discharge 
Diagnosis 
n R R² Adjusted 
R² 












Model 1   .796 .633 .621 50.107 <.0001 .633 50.107 <.0001 48.253 (43.805 – 52.701)  <.0001 
PD 47         -8.020 (-10.337 – -5.703) -.796 <.0001 
             
Model 2   .811 .657 .619 17.239 <.0001 .024 .928 .407 34.911(11.381 – 58.442)  .005 
PD 47         -7.464 -10.035 – 4.892) -.741 <.0001 
EpiTrack 41         .221 (-.440 – .881) .079 .498 
SCI 44         .385 (-.246 – 1.017) .156 .222 
              
PNES 
Group 
Model 1   .817 .667 .645 30.036 <.0001 .667 30.036 <.0001 52.328 (46.158 – 58.498)  <.0001 
PD 18         -9.562 (-13.281– 5.843) -.817 <.0001 
             
Model 2   .915 .838 .801 22.417 <.0001 .171 6.864 .009 16.559 (-11.937 –45.055)  .231 
PD 18         -4.927 (-8.846 – 1.008) -.421 .018 
EpiTrack 19         .581 (-.298 – 1.461) .189 .177 
SCI-CS 20         1.241 (.379 – 2.102) .462 .008 




There was no difference in QOL, anxiety or depression scores in the two groups. In previous 
studies people with PNES reported lower QOL and scored higher on measures of 
psychopathology than people with epilepsy (G. H. Rawlings et al., 2017; Testa et al., 2007). It 
is possible that the high levels of symptoms in both groups reflect the complexity of the 
population served by the SEC, which may account for the difference with previous research 
findings. 
 
Psychological distress was the best predictor of QOL at admission and discharge in both 
groups with large effect sizes. This is in concordance with previous research (G. H. Rawlings 
et al., 2017), including a previous review (B. Jones et al., 2016b). In the PNES group, change in 
psychological distress was significantly associated with change in QOL, a one unit decrease in 
psychological distress was associated with 7.9 points increase in QOLIE-31 score in model 1. 
Symptoms were significantly reduced on all measures and QOL improved at the time of 
discharge in the epilepsy group. At discharge, QOL improved, and anxiety symptoms reduced 
in the PNES group. 
 
Insomnia scores predicted QOL in the epilepsy group at admission, but not in the PNES group. 
Only the change in insomnia scores was predictive of change in QOL score and this was only 
in the PNES group. Previous research in the area is limited but can be compared with one 
study that found no correlation between sleep and QOL in people with PNES (Erickson et al., 
2019). 
 
 Cognition scores were associated with QOL in the PNES group at admission. . Cognitive scores 
improved across admission in both groups (although not statistically significant in the PNES 
group) and it appears that the change in score meant the measure was no longer associated 
with QOL at discharge.  This compares with recent research that found cognitive scores were 
a significant predictor of QOL in people with PNES (Johnstone et al., 2021). In this study 
participants were assessed on a cognitive screening test during their admission and not at 
two time points as in the present study.  
 70 
Clinical Significance 
The improvement in anxiety and depression at discharge were clinically meaningful.  Within 
both groups, the average score on the NDDI-E went from above the cut off for major 
depression to below the cut-off. GAD-7 scores of the PNES group reduced from moderate 
anxiety to mild anxiety and epilepsy group scores reduced from severe anxiety to mild anxiety.  
It should be noted that these changes occurred in the context of an inpatient stay; where the 
ward environment could have a positive or negative impact that may not translate beyond 
their admission. Follow-up post discharge would allow for disambiguation.  
 
The SEC is a specialist centre providing patients with high standards of care, facilities and 
knowledge. It is possible that changes in scores reflect the beneficial role of admission to the 
SEC.  Further examination of the component parts of admissions would allow for an 
understanding on what is impacting on psychological distress, sleep and cognition and 
ultimately bringing about improvements in QoL. 
 
Standard protocol following PNES diagnosis is cessation of AEDs which can be associated with 
an increase in cognition scores (depending on AED). Depression is known to have an effect on 
cognitive functioning; thus, it is possible the change in psychological distress scores seen in 
both groups across admission could account for some of the variation in cognitive scores. 
 
Strengths and Limitations  
Multiple time points within the design allowed for investigation of change. The use of a 
control group would improve the design of the study however this would be difficult in 
practice. Following exclusions and pairwise comparisons, the final sample did not reach the 
predicted sample sizes in all analyses. The study may be underpowered to detect differences. 
It is unknown whether the missing data points are from a subset of participants with 
differences to the sampled population. These individuals represent a unique cohort of 
patients referred for specialist treatment.  The sample is representative of individuals with 
PNES and epilepsy with high care needs but may not be representative of individuals who are 
diagnosed with PNES and epilepsy within general neurology settings.  
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The outcome measures are widely used in PNES samples however the QOLIE-31 has not been 
validated within PNES samples. This is a limitation with PNES research across the field. 
Although attempts were made to base diagnosis on EEG data, for some individuals there were 
no captured seizure events and diagnosis was made on eyewitness description of typical 
events. Therefore, there may be inaccuracies in the discharge diagnosis and confounding of 
PNES and epilepsy groups.   
 
Clinical Implications 
Clinical implications of the present study indicate screening and management of anxiety and 
depression is indicated for individuals with PNES and epilepsy. This should be reflected in care 
pathways of across all levels, not only in specialist services. Dissemination of this via 
guidelines and best practice could improve practice and awareness of the importance of 
addressing these issues.  
 
A person centred, psychological formulation of difficulties, including the development and 
maintaining factors of PNES episodes and their relationship with psychological distress would 
be pertinent to address the needs of individuals. This could be aimed at integrating the 
experience of anxiety and depression with the onset of PNES and building an understanding 
of whether low mood or anxiety precipitate PNES events or vice versa. Building an individual’s 
knowledge of their own difficulties through a formulation-based approach can empower 
people to make change and engage in treatment pathways. A formulation approach in the 
context of MDT working can aid individuals to engage with team members.  
 
The high prevalence of psychopathology, sleep disturbance and poor comparative QOL in 
both groups indicates a need for MDT intervention, which is already indicated within SIGN 
guidelines for epilepsy. No such guidelines exist for PNES management and it would be 
pertinent for this to be included in screening and management recommendations. Clear and 
structured pathways within healthcare systems to address these widespread difficulties in 
both populations are needed. These data taken together with previous research may be 
useful to consider in the development of guidelines for the management of PNES within the 
UK. 
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Future research to examine the stability of changes in QOL, psychological distress, sleep and 
cognition following admission is recommended. Insomnia appears to be present across both 
groups and further research to indicate whether this can be modified via sleep intervention 
would be indicated. The present study excluded individuals with co-occurring PNES and 
epilepsy and those with learning disabilities. These individuals are often excluded from 
research to control for confounding effects. Future research into the associates of QOL in 
these groups is recommended.   
 
Conclusions 
It appears that interventions to improve anxiety, depression and sleep may benefit QOL.  
Sleep and cognitive scores account for a small proportion of the variance in QOL scores and 
further research is warranted to develop the understanding of the relationship between sleep 
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Appendix 2.5 Normality Assessment 
 
Table 1. D values from Kolmogorov-Smirnov Values   
Variable Epilepsy Group PNES Group 
Length of Admission (days) .123* .119 
Age .129* .131 
SIMD  .104 .242** 
QOLIE-31 Admission Score .088 .139 
QOLIE-31 Discharge Score .097 .107 
NDDI-E Admission Score .110 .155 
NDDI-E Discharge Score .151** .131 
GAD-7 Admission Score .135* .176 
GAD-7 Discharge Score .151** .139 
EpiTrack Admission Score .144* .103 
EpiTrack Discharge Score .152* .225* 
SCI Admission Score .086 .080 
SCI Discharge Score .115 .109 
QOL-Change Score .154* .135 
GAD-7- Change Score .098 .150 
NDDI-E- Change Score .133* .198* 
SCI- Change Score .089 .197* 




*p <0.05,   ** p <0.01,   ***p<.001 
PNES= Psychogenic non-epileptic seizures, SIMD= Scottish index of Multiple deprivation, QOLIE-31= Quality of 
life in epilepsy-31, GAD-7= Generalised anxiety disorder – 7, NDDI-E= Neurological Disorders Depression 




Appendix 2.6 Assesment OF Multicollinearity : QOL at Admission  
With regards to multicollinearity within the regression models, none of the correlations 
within the matrix exceeded 0.80, however the correlation between GAD-7 and NNDI-E 
admission scores in the epilepsy group were approaching 0.80. VIF values were all <10 and 
the average VIF  was 1.617. No tolerance values were less than 0.1. Several condition indexes 
were greater than 15, and one was greater than 30 indicating possible collinearity. In the 
epilepsy group there was a large proportion of the variance on the same small eigenvalue for 
GAD-7 and NDDI-E, indicating possible collinearity between the two variables. This was not 
present in the PNES group. Results of the Durbin Watson test indicated residuals were unlikely 
to be correlated. Scatterplots appeared evenly dispersed. On inspection of the histograms 
and P-P plots for normality of the residuals, the distribution of residuals in the PNES group 
looked to be non-normally distributed. Taking the above into consideration it appears 
multicollinearity may be present, and residuals may be non-normally distributed. Therefore, 





















Appendix 2.7 Regression Values 
Table 4. Summary of hierarchical multiple regression analysis for variables predicting QOLIE-31 admission scores in Epilepsy or PNES groups.  
 
PNES= Psychogenic non-epileptic seizures, SIMD= Scottish index of Multiple deprivation, QOLIE-31= Quality of life in epilepsy-31, GAD-7= Generalised anxiety disorder – 7, 
NDDI-E= Neurological Disorders Depression Inventory, SCI= Sleep condition index
Discharge  
Diagnosis 
n R R² Adjusted 
R² 
F Sig. Change Statistics Coefficients   











Model 1  .621 .385 .354 12.219 <.0001 .385 12.219 <.001 61.836 (43.25 – 80.42)  <.0001 
NNDI-E 52 
        
-.654 (-2.05 – .74) -.173 .348 
GAD-7 52 
        
-1.262 (-2.22 – -.30) -.484 .011 
Model 2   .738 .545 .496 11.084 <.0001 .160 6.501 .004 42.134 (20.78 – 63.49)  <.0001 
NDDI-E  
        
-.749 ( -1.10 – .50) -.198 .231 
GAD-7  
        
-.976 (-1.87 – .08) -.374 .034 
EpiTrack 46 
        
.314 (-.12 – .75) .165 .151 
SCI 52 
        
.603 (.23 – .98) .382 .002 
PNES 
Group 
Model 1  .574 .330 .246 3.936 .041 .330 3.936 .041 53.667 (30.64 – 76.70)  <.0001 
NNDI-E 21 
        
-.413 (-1.90 – 1.08) -.141 .565 
GAD-7 23 
        
-1.106 (-2.26 – 0.05) -.487 .060 
Model 2   .862 .743 .669 10.102 <.0001 .413 11.233 .001 3.451 (-33.34 – 40.24)  .843 
NNDI-E  
        
.279 (-.94 – 1.50) .095 .631 
GAD-7  
        
-1.531 (-2.40 – 67) -.674 .002 
EpiTrack 20 
        
1.554 (.85 – 2.26) .688 <.001 
SCI 23 
        




A hierarchical multiple regression analysis of the epilepsy group with QOLIE-31 as the 
dependent variable revealed that at stage one, GAD-7 and NDDI-E explained 38.5% of the 
variance (p < 0.001). The additional outcome measures, SCI and EpiTrack were then added, 
explaining a further 16% (p< 0.001). The final model accounted for 54.5% of variance (Table 
4). In the PNES group GAD-7 and NDDI-E explained 33% of the variance (p <0.001) as stage 
one. The additional outcome measures, SCI and EpiTrack were added second, explaining a 
further 41.3% (p< 0.001). The final model accounted for 74.3% of the variance. 
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Appendix 2.8 Multicollinearity Assessment: Psychological Distress Regression 
The results from the regression model with psychological distress as the independent 
variable. No indication of multicollinearity between variables, all correlations < 0.70. VIF 
values all <10, average VIF = 1.32. No tolerance values <.10 and all index conditions were 
< 15. Variance proportions were satisfactorily distributed across the eigenvalues. 
Results of the Durbin Watson test indicated residuals were unlikely to be correlated. 
Scatterplots appeared evenly dispersed. On inspection of the histograms and P-P plots 
for normality of the residuals, the distribution of residuals in the PNES group looked to 
be non-normally distributed, however K-S testing of the residuals from both the 





Appendix 3: Original Research Proposal 
 
 
Research Protocol Version 1 
Full Title: Feasibility and acceptability of a brief psycho-education session following diagnosis 
of Psychogenic Non-Epileptic Seizures for patients and carers within a specialist epilepsy 
centre. 
Short Title: Understanding PNES 
 
Introduction 
Rationale and Background 
Psychogenic non-epileptic seizures (PNES) are transient paroxysmal events, characterised by 
altered responsiveness, motor and sensory symptoms and emotional signs. PNES appear similar 
to epileptic seizures but originate from psychological processes rather than abnormal brain 
activity (Hubsch et al., 2011). The estimated incidence of PNES is between 1.4–4.9/100,000 per 
year and the estimated prevalence between 2 and 33/100,000 in the general population (Asadi-
Pooya & Sperling, 2015).  Historically PNES has been a diagnosis of exclusion, made after ruling 
out neurological disorders, primarily epilepsy. The diagnosis of PNES falls within Functional 
Neurological Symptom (Conversion) Disorder, Somatic Symptom Disorder, Dissociative Disorder 
or Post Traumatic Stress Disorder in the DSM-5 (American Psychiatric Association, 2013). Within 
the ICD-10 classification system (World Health Organization, 1992) PNES is specified as 
“Conversion Disorder with seizures or convulsions”, both systems accept PNES events as non-
volitional, occurring without intent.  
 
The complexities and specialist knowledge required to differentiate PNES from epilepsy means 
diagnosis often takes places within neurology services and specialist epilepsy centres. The gold 
standard for diagnosis involves the use of video electroencephalogram (VEEG) to rule out 
epileptic seizures. In the absence of EEG or VEEG, diagnosis can be made on review of 
semiological data from direct or video observation (LaFrance, Baker, Duncan, Goldstein & 
Reuber, 2013). Misdiagnosis is common and many individuals with PNES initially receive a 




with anti-epileptic medication and re-sective surgery for medically intractable epilepsy. It has 
been estimated that approximately one in five patients who first present at a specialist seizure 
clinic receive a diagnosis of PNES (Angus-Leppan, 2008).  
 
Professionals can often struggle to appropriately engage and support individuals with PNES 
following an exclusion of neurological diagnosis. When individuals are diagnosed with PNES in 
neurology centres they are most often referred for psychological treatment externally as their 
diagnosis is not classes as a neurological/medical disorder. The distinction between psychogenic 
and epileptic seizures can be confusing for patients and medical professionals without specialist 
knowledge of the disorder (Rawlings and Reuber, 2018). Patients can be reluctant to accept that 
their seizures are not associated with abnormal electrical activity and may find the concept of 
a psychological origin to be invalidating and confusing (Stone et al., 2004). At the stage of PNES 
diagnosis individuals have typically experienced prolonged periods, typically years, of 
conceptualising their symptoms as epilepsy, generated by brain abnormality.  
 
It has been reported that the communication style, timing and content of PNES diagnosis can 
have a significant impact on outcome, with evidence to suggest that good communication can 
lead to reduction and resolution of PNES in some individuals (Kanner et al., 1999; Hall-patch et 
al., 2010; LaFrance, Reuber, & Goldstein, 2013). Those who do accept PNES diagnosis 
demonstrate better outcomes (Ettinger, Devinsky, Weisbrot, Ramakrishna, & Goyal, 1999). 
However, recent evidence suggests that diagnosis and communication of PNES using 
standardised protocol delivered by the multidisciplinary team may not be effective at reducing 
the burden of PNES and patients require greater knowledge about and treatment of their 
disorder (Mayor et al., 2010).  
 
This progression of knowledge surrounding the diagnosis of PNES continues to develop through 
research and clinical practice. A systematic review by Brown and Reuber (2016) summarised the 
current literature on PNES and outlined 4 overarching models (1) PNES as the activation of 
dissociative material, (2) PNES as a hard-wired response, (3) PNES as a physical manifestation 
of emotional distress and (4) PNES as a learned behaviour. The authors highlight the variable 
quality of studies on which these models are based and in a subsequent paper developed the 
Integrative Cognitive Model (ICM) of PNES. The ICM incorporates general predisposing and 
perpetuating factors, biological, psychological and social components with various mechanisms 




theory of “medically unexplained symptoms” and introduces the concept of a “seizure scaffold” 
which represents observable and subjective elements of PNES. The ICM suggests there are 
general factors that contribute to PNES dysfunction such as chronic stress. In doing so the model 
eliminates the presumption that abuse, especially in childhood, is the central cause of PNES. 
Research and understanding of PNES has advanced greatly in the past 25 years, however 
elements of these models tend to be mentioned only briefly in explanations of PNES and very 
few elements appear within protocols developed for communication of PNES to patients (Hall-
Patch et al., 2010).  
 
It is therefore important to develop communication strategies for delivering PNES diagnosis that 
enhance acceptance and facilitate a clear understanding of the PNES. Given the difficulties 
surrounding the diagnosis and diagnostic process, strategies that link in with treatment 
pathways and make clear as to what does and does not cause PNES are necessary to help 
individuals conceptualise their difficulties as distinct from epilepsy. A number of research 
studies have evaluated the acceptability and effectiveness of communication strategies and 
brief psycho-education programs in various contexts (Hall-Patch et al, 2010; Baxter et al, 2012; 
Chen et al, 2014; Mayor et al, 2013; Hingary et al, 2016; Wiseman et al, 2016). However, there 
are currently no guidelines for communication of diagnosis or treatment of PNES within the 
National Institute for Clinical Excellence (NICE) guidelines, the Matrix or the Scottish 
Intercollegiate Guidelines Network (SIGN).   
 
A report from the International League Against Epilepsy, Nonepileptic Seizures Task Force 
suggests “the optimal treatment strategy, includes psychological approaches and 
pharmacological treatment (SSRI) in the absence of any currently available high-quality studies” 
(Gasparini et al, 2019). Psychological therapies indicated for the treatment of PNES include 
psychotherapy, “Cognitive Behavioural Therapy (CBT) and its modalities”, EMDR and family 
therapy (Milán-Tomás, Persyko, del Campo, Shapiro & Farcnik, 2018).  A review by the 
International League Against Epilepsy suggests involvement of family and carers at diagnosis as 
favourable practice (LaFrance, Baker, et al., 2013). Individuals with PNES can have high care 
needs and there is evidence to suggest that caregiver attitudes impact on acceptance of PNES 
from a previous study by Duncan, Graham and Oto, 2014. This study assessed patient and 
caregiver reactions to PNES and the association between reactions and attendance of follow-
up appointments and long-term outcomes. They found caregivers with favourable acceptance 




Norman, Sharpe and Reuber (2015) report psychological factors were viewed as more relevant 
by relatives of individuals with PNES than patients.  Taken together this evidence suggests that 
carer perceptions of PNES may play an important role in management of PNES. 
 
Aim/Primary and Secondary Objectives 
The primary aim of this research is to investigate the acceptability of a targeted education 
session for patients and their carers diagnosed with PNES within the William Quarrier Scottish 
Epilepsy Centre, a specialist centre assessing and treating patients from across Scotland. This 
education session will be based on the principals of the ICM of PNES as outlined above (Brown 
& Reuber, 2016). The session aims to provide patients and carers with information regarding 
their diagnosis, offering to conceptualise symptoms and experiences by specific psychological 
mechanisms implicated in the development and maintenance of PNES.  
 
The study aims to be relevant and meaningful to both patients and carers, who have in previous 
studies reported confusion following diagnosis (Hall-Patch et al., 2010). Based on previous 
research that reports benefits of brief psycho-education interventions in this population 
(Novakova, Harris, Rawlings, & Reuber, 2019) we predict that individuals will engage with and 
value the current approach. The secondary objective is to investigate the feasibility of running 
a pilot trial of the psycho-education session within the specialist centre, evaluating the utility of 
the proposed outcome measures. With reference to likely potential recruitment and retention 
rates of both patients and carers in this environment.   
 
Methodology 
Inclusion Criteria for Patients: 
• Presence of PNES as confirmed by consultant epileptologist or clinical nurse specialist 
in epilepsy. Individuals who are admitted with known PNES to rule out comorbid 
epilepsy will also be included in the study if they have not received previous 
psychological input for PNES. 
 
Inclusion Criteria for Patients and Carers:  
• Individuals 16 years of age and older 
• Ability to give informed consent.  
• Fluent in English 





Exclusion Criteria for Patients and Carers: 
• Known moderate to severe cognitive impairment including learning disability or 
acquired brain injury.  
• Individuals who have completed previous psychological intervention for PNES.  
 
Study Design/Plan 
Patients diagnosed with PNES or comorbid PNES and Epilepsy within the WQSEC, following 
inpatient stay will be recruited. They will be asked to identify a family member or carer who will 
also be recruited into the research.  
 
1. Following diagnosis, the consultant or relevant clinician will ask the patient if they 
would be interested in learning more about a study investigating the acceptability and 
feasibility of a brief education session of PNES for patients and carers. The Participant 
Information sheet (Version 1; 01/03/2020) will be given for patients to read and share 
with their identified carer.  
2. Potential participants will then register interest by removing the tear off strip at the 
bottom of the information sheet (place into provided envelop) and give to a member 
of their clinical team to be handed to reception at the WQSEC. 
3. A member of the research team will then contact the potential participant to organise 
a consenting visit. This will usually be with the trainee clinical psychologist during 
inpatient stay. The research will be summarised, and the participants will have the 
opportunity to ask questions about the research. Informed Consent for research will be 
gained and documented using the Consent Form (Version 1; 01/03/2020).  
4. The trainee clinical psychologist will then administer the Patient Brief Illness Perception 
Questionnaire (BIPQ, Broadbent, Petrie, Main, & Weinman, 2006) and the Carer (BIPQ). 
This questionnaire has been adapted (with author permission) for use within PNES 
population. Demographic data will also be collected from both the patient and carer. 
5. The patient and carer will then be invited to participate in the brief psycho-education 
session regarding PNES diagnosis and management. The education session will be 
delivered by the centres clinical psychologist and will approximately 60 minutes in 
duration. The session will occur during inpatient stay in one of the available clinical 




6. Following the education session, the Trainee Psychologist will administer the BIPQ again 
to both patient and carer. A feedback interview will then be conducted for both the 
patient and carer separately. Qualitative interview questions are outlined below. 
 
Psycho-Education Session Details 
The education session aims to provide patients and carers with a coherent understanding of the 
psychological mechanisms involved in PNES and how these interact with physical processes to 
generate various symptoms of PNES.  The session will be delivered by the Centres Clinical 
Psychologist. It will be delivered in one session, approximately 60 minutes in length. 
Accompanying handouts will be provided for both the patient and carer to keep. Carers who 
are unable to attend the WQSEC can participate in the session via video or telephone 
conferencing. The material covered will be based on the following key concepts of the ICM of 
PNES: 
 
• PNES develops in the context of inhibition processing dysfunction. The cause of which 
can be chronic stress, arousal or other factors compromising high level cognitive 
processing. 
• PNES is understood as a conditioned reflex with contributions from inherent reflexes 
(freeze or startle), physical symptoms (pre-syncope, dissociation, hyperventilation and 
head injury) and personal knowledge or modelling. These factors come together to 
produce the individualised seizure scaffold.  
• Behaviourally the seizure scaffold is described as the perceptions and motor activities 
experienced by the individual. 





Acceptability will be assessed as detailed in a previous study by Saracutu, Edwards, Davies & 
Rance, 2018) involving qualitative questions probing education session coherence and 
experiences of taking part. This will be asked via the following qualitative interview questions 
and the answers to these questions will be transcribed and collated allowing for analysis of 





1. What did you learn from the education session? 
2. What parts of the session did you find most useful? Where there any aspects that you 
enjoyed? 
3. What did you like least about the session? What do you think could be improved? 
4. Were there any difficulties in taking part? 
5. Are there any changes in how you view your PNES? If the answer is yes, what are they? 
6. Is there anything you plan to do differently following the session? 
7. Would you recommend this type of session to someone you cared about? 
 
Demographic information will be collected for purposes of describing the groups. The BIPQ 
(Broadbent, Petrie, Main & Weinmen, 2006) will be used to measure illness perceptions in PNES.  
The BIPQ comprises 9 items that respondent’s rate on a 10-point Likert scale, a higher total 
score indicates a more threatening view of the illness. There is also one causal question which 
is qualitative and can be analysed categorically. The questionnaire has demonstrated good 
internal consistency and test-retest reliability in a variety of patient populations (Broadbent et 
al., 2015). The BIPQ has been modified for PNES population with permission of the authors. 
 
Data from the WQSEC research database will be used to form a comparison group, this will 
consist of BIPQ scores from anonymised individuals pre and post PNES diagnosis. This dataset 
will comprise patients who received a diagnosis of PNES within 4 months prior to the start date 






Justification of sample size 
Lancaster, Dodd and Williamson (2004) suggest a sample size of 30 participants in feasibility and 
acceptability studies. Data from the WQSEC demonstrate that for the period April 2016 to 
March 2017 there were 12 patients diagnosed with PNES alone, 28 patients with mixed 
diagnosis (PNES and Epilepsy) and 4 patients with PNES, with unconfirmed comorbid epilepsy. 
A total of 44 patients for the year with confirmed PNES diagnosis (or approximately 22 over six 
months). Informal discussion with staff from the centre indicates that admissions have since 




56% and 90% (Mayor et al., 2012; Stone et al., 2004). We aim to recruit 30 patients to the study 
over a 6-month period.  
 
Planned Data Analysis 
As a feasibility study the analysis will focus on determining if the proposed psycho-education 
session is acceptable and would likely succeed in achieving recruitment in the current setting. 
As such the planned analysis will be largely descriptive in nature with features of qualitative 
data analysis to assess participant experiences. Feasibility will be assessed through recording 
the number of patients referred by their diagnosing consultant, the number who agree to 
participate in the research and the number who subsequently attend the session with a career. 
This will be used to estimate realistic recruitment rates within the centre over a given period in 
future research.  
 
We will investigate if there are differences between the rates of change in illness perception 
between those receiving the session in the feasibility study and those diagnosed in the centre 
in the previous 4 months. As this is a feasibility study, we will not use this comparison for 
calculation of effect size. 
 
Ethics  
Health and Safety Issues  
Standard personal safety risk assessment to be followed when working with patients and carers. 
The purpose of inpatient assessment at the SEC is to capture occurrence of seizure during 
admission, as such physical risks to patients will not be over and above those consented to as 
part of the inpatient assessment. 
 
Criteria for discontinuation 
Post diagnostic periods are a potentially sensitive time and care will be taken to ensure patients 
and carers are not put under any undue distress by discussing research options following their 
diagnosis. This will be left to the judgement of the diagnosing consultant. Patient views on their 
diagnosis will be handled sensitively and any monitored throughout the session.  Should any of 
the participants become overly distressed with the presentation of information regarding PNES 
diagnosis or management techniques, the session will be terminated. This will be based on 




psychologist. Debriefing will be available for participants to discuss their concerns and 
experiences. 
 
Procedure for collecting data. 
Data will be collected via pen and paper forms and notes taken at interview. Participants will be 
assigned a participant number at the time of consent and all personal information will be 
anonymised. Paper copies will be stored in a locked file cabinet within the WQSEC. Data will be 
kept in accordance with GDPR and local NHS GGC health board policies. 
 
Ethical Issues  
The principal investigator will ensure the study will be carried out in accordance with the ethical 
principals in the Research Governance Framework for Health and Community Care, Second 
Edition, 2006 and applicable legal and regulatory requirements.  
Before the start of the study the protocol and informal consent form will be reviews and 
approved by the Ethics committee (EC). Management approval for the research study will also 
be obtained from the WQSEC.  
 
Finance and Indemnity 
Research costs will be funded by the University of Glasgow, for the project these are negligible 
costs amounting to printing of materials and outcome measures which are freely available. 
Research members working on the project will be covered for negligent harm through 
University and/or NHS indemnity schemes.  
 
Publication 
Study results will be published as part of Doctoral Thesis by the trainee clinical psychologists 
and will also be submitted to peer reviewed journal for publication.  
 
Timetable  
Submission Title Deadline Date 









Data Analysis and Write Up November – 
January 2021 
Submission of Thesis Report 28th February 2021 
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Appendix 4: Alternative Major Research Project Proposal 
 
Research Protocol Version 3 03/11/2020 
Full Title 
Investigating quality of life in adults with epilepsy and psychogenic non epileptic seizures who 
attend a national specialist epilepsy centre.     
 
Short Title 
Scottish Epilepsy Centre Outcomes 
 
Introduction 
Epilepsy monitoring units provide specialist assessment, diagnosis and treatment for individuals 
with epilepsy and psychogenic non-epileptic seizures (PNES). The main aims for patients 
entering these centres are typically to clarify diagnosis and reduce seizure frequency.  
Increasingly it is being recognised that quality of life for patients comprises more than freedom 
from seizures. Individuals with epilepsy and PNES are affected by a complex range of biological, 
psychological and social factors which impact on quality of life. The association amongst various 
biopsychosocial factors, patient quality of life and wellbeing is emerging within the literature 
and will be the focus of the current research project. 
 
Epileptic seizures and PNES appear similar in their clinical presentation, however they differ in 
their underlying neurophysiological processes. Epileptic seizures are characterised by abnormal 
neuronal discharge, whereas PNES originate from psychological processes that are not 
associated with abnormal brain activity (Hubsch et al., 2011). Recently there has been 
significant development into deriving a comprehensive understanding of the processes leading 
to the development and maintenance of PNES. Brown and Reuber (2016) outlined four 
overarching processes that are implicated in PNES. (1) PNES as the activation of dissociative 
material, (2) PNES as a hard-wired behavioural response, (3) PNES as a physical manifestation 
of emotional distress and (4) PNES as a learned behaviour. Their Integrated Cognitive Model of 
PNES supports an understanding of PNES as unintentional events and moves away from early 





The complexities and specialist knowledge required to differentiate PNES from epilepsy means 
diagnosis often takes places within tertiary neurology services or specialist epilepsy centres. The 
gold standard for diagnosis involves the use of video electroencephalogram (VEEG) to rule out 
epileptic seizures. In the absence of EEG or VEEG, diagnosis can be made on review of 
semiological data from direct or video observation (LaFrance, Baker, Duncan, Goldstein & 
Reuber, 2013). Misdiagnosis is not uncommon, especially out with specialist centres and many 
individuals with PNES initially receive a diagnosis of epilepsy. Differential diagnosis is important 
for management of risks associated with anti-epileptic medication; appropriate response to 
status epilepticus and in planning resective surgery for medically intractable epilepsy. It has 
been estimated that approximately one in five patients who first present at a specialist seizure 
clinic receive a diagnosis of PNES (Angus-Leppan, 2008). Patients have many and diverse 
experiences within various pathways leading to a diagnosis of PNES. It can be difficult for 
patients to accept a diagnosis of PNES, individuals have been reported to be angry and confused 
with the diagnosis (Thompson et al, 2009). 
 
The distinction between psychogenic and epileptic seizures can be confusing for patients and 
medical professionals who lack specialist knowledge of the disorders (Rawlings and Reuber, 
2018). Misconceptions around the diagnosis of PNES may contribute to reluctant of some 
patients to accept the concept of psychogenic seizures and patients have been reported to see 
the diagnosis as invalidating and confusing (Stone et al., 2004). At the point of diagnosis 
individuals with PNES and their social networks including families, friends, teachers and 
colleagues have typically experienced years of conceptualising their symptoms as epilepsy, 
generated by brain abnormalities. Individuals with epilepsy experience high levels of perceived 
and objective stigmatization in society (Fiest et al, 2014) as do individuals with PNES, by both 
professionals and lay people (Karakis et al, 2020).  
 
Research indicates that individuals with epilepsy and PNES experience higher levels of 
psychopathology and poorer self-reported quality of life (QoL) than the general population 
(Jacoby, Snape and Baker, 2008; Kobau et al, 2014; Abe et al, 2020). Furthermore, people with 
PNES consistently report poorer overall QoL than matched samples with epileptic seizures 
(Testa et al, 2007), indicating that both diagnoses are associated with a significant detriment to 
QoL.  A systematic review by Jones, Reuber and Normal (2015) investigated for correlates of 




correlate of Health Related QoL. In their review of 14 studies, they also found dissociation, 
somatic symptoms, escape‐avoidance coping strategies, and family dysfunction to be 
associated with poor Health Related QoL. Interestingly they found no evidence to support the 
association between Health Related QoL, seizure frequency, and demographic factors. This 
contrasts with a previous review which found that clinical factors such as seizure frequency and 
severity, as well as psychological factors, impact on QOL in people with epilepsy (Taylor et al, 
2011). 
 
So, whilst seizure frequency appears to be associated with QoL at least to some degree in both 
individuals with epilepsy and PNES, it may have less of an impact on QoL in those with PNES. 
This indicates that it is important to identify other factors that contribute to and are associated 
with QoL in individuals with PNES only. 
 
Study Summary  
The Scottish Epilepsy Centre (SEC) is a specialist inpatient assessment and treatment centre 
providing services for individuals across Scotland. During inpatient stay individuals may undergo 
a range of specialist assessments to help diagnose and manage epilepsy and/or psychogenic 
non-epileptic seizures (PNES). Seizure reduction is a primary focus for patients and clinicians 
alike. The SEC routinely evaluates anxiety, depression and indicators of QoL at admission and 
discharge to help identify individuals who may benefit from additional intervention including 
for mental health and well-being needs.  
 
The current research project aims to build a better understanding of the association between 
QoL and a range of factors in individuals with PNES and Epilepsy by investigating outcomes 
across inpatient admission to the SEC.  
 
Study Aims 
The primary aim of this research is to investigate factors associated with QoL in PNES and 
Epilepsy groups. Specifically, the association between QoL and demographic characteristics, 
self-reported mental health scores, sleep quality scores, screening of cognitive functioning and 
medication burden.   
 
The secondary aim is to investigate if QoL ratings change during inpatient stay at the SEC and if 




epilepsy and PNES groups. Seizure frequency does provide an important metric in terms of 
severity and burden of disease, seizure frequency will be analysed within groups as a descriptive 
statistic and change in seizure frequency will be analysed across participant groups to provide 
information to the SEC. Changes in seizure frequency and seizure frequency as a predictor of 
QoL is however not the focus of this research. 
 
Methods 
This research will be achieved by conducting a retrospective cohort analysis of routine data 
collected from inpatients attending the SEC. The analysis will be conducted on data which 
comes from an existing database, collected between 1st of March 2019 to 31st March 2020. 
Patients give consent for data to be used in research and/or audit at admission and all data 
analysis in the present study will be conducted on fully anonymised data. 
 
Participants 
Participants will be those who were admitted to the SEC within the aforementioned dates and 
gave consent for their data to be used in future research and audit. Inpatients at the SEC are 
most commonly referred in order to: 
(1) clarify diagnosis and understand the nature of seizures 
(2) record physiological and behavioural data during seizures 
(3) assess how seizures are affecting health and life 
(4) assess how factors in an individual’s life influence their seizures and health 
(5) assess if seizures and illness affect an individual’s mood and memory 
(6) make changes to treatment and medications in a safe environment 
(7) provide individual advice and support to help individuals live with epilepsy 
Individuals who are admitted to the SEC include those who have epilepsy only, PNES only and 
mixed epilepsy and PNES. Professionals within the centre endeavour to provide concrete 
diagnosis however due to the nature of the difficulty in differentiating between PNES and 
epilepsy, a number of individuals are discharged with an “uncertain” diagnosis. Participant 











The dataset includes patients who: 
• were admitted to the SEC from the time point 1st of March 2019 to 31st of March 2020 
and gave consent for their data to be used for research and audit purposes 
• were aged 16 and over at the date of admission 
• had confirmed diagnosis or suspected diagnosis of Epilepsy or PNES 
• were fluent in English 
Exclusion Criteria: 
The dataset excludes patients who: 
• did not give consent for their data to be used for research.  
• had a moderate to severe cognitive impairment including learning disability or acquired 
brain injury. Individuals with moderate cognitive impairment were provided with 
alternative outcome measures appropriate for individuals with Learning Disability. The 
decision to allocate patients with the alternative measures was made based on 
information included by the referrer or based on clinical judgement of nurse specialists 
within the centre, following discussion with patients and carers pre-admission.  
Justification of Sample Size 
Due to the nature of the data set the sample size is fixed, consisting of 85 patients with a 
diagnosis of epilepsy only, 26 patients with a diagnosis of PNES only and 36 patients with a 
mixed or unclear diagnosis. Considering those with epilepsy or PNES only the study will have 
80% power to detect a standardized difference between groups (effect size) of 0.56, at a 5% 
significance level, for a normally distributed continuous measure.  
 
Within the smaller diagnostic subgroup, there will be 80% power to detect a correlation of 0.25 






The anonymised data will be accessed and stored as per WQSEC data management guidelines. 
The researcher will be given an honorary WQSEC staff account within the secure Office 365 
platform which the centre uses to store and share data securely. This will be accessed online via 
NHS computers laptops and personal devices. Data will only be stored within the WQSEC Office 
365 platform. 
The original file format will be an Office Excel document, the researcher will input this data to 
create both SPSS and “R” file documents to carry out statistical analysis. These three files will 
be accessible to the student research Demitra Tsivos. These files may be viewed through screen 
share with the academic and clinical supervisors, Thomas McMillan and Iain Campbell as well 
as the designated statistician Alex McConnachie. No patient identifiable data will be stored on 
University of Glasgow or personal computers. 
Planned Data Analysis 
1. The data will initially be analysed to check for normal distribution to determine if parametric 
or non-parametric analysis is appropriate. Descriptive data will be compiled for the dataset as 
a whole and per patient group, descriptive data available is:  
• Age 
• Gender 
• Deprivation (based on postcode and Scottish Index of Multiple Deprivation). 
The researcher will receive the deprivation score only, not postcodes to comply 
with patient confidentiality and keep data anonymous.   
• Diagnosis: “Epilepsy Only”, “PNES Only”, “Mixed and/or Unclear Diagnoses”  
• Length of inpatient stay at the SEC (days) 
 
2. In order to analyse which factors are associated with QoL on admission, a multivariable linear 
regression analysis will be carried out with QOLIE-31 as the dependent variable and admission 
measures for the NDDI-E, GAD-7, SCI, MoCA, EPItrack and deprivation index as the independent 
variables. This will be done first with patients condensed into one group and subsequently with 
three separate patient groups PNES, epilepsy and “Mixed”. The reason for this is due to small 





3. An analysis of Covariance (ANCOVA) will be conducted to investigate if there is a significant 
difference in scores on QoL-31, NDDI-E, GAD-7, SCI, MoCA and EPItrack at admission (Time 1) 
and Discharge (Time 2), with the length of admission as the covariate. If there is a significant 
difference found in measures from admission to discharge, subsequent independent sample t-
tests will be employed to identify whether there are differences between the patient groups. 
 
4. Should there be a significant change in QoL ratings over time, it will be followed up with 
regression analysis to determine what factors predict change in self-reported QoL.  
The total list of variables that will be supplied to the researcher is 
• Date of admission and discharge 
• Age 
• Gender  
• Scottish Index of Multiple Deprivation 
• Medications on admission and at discharge (type and dose)  
• Services received during admission (neurology, neuropsychiatry, 
neurophysiology, neuropsychology, specialist nursing) 
•  Neurological Disorders Depression Inventory for Epilepsy at admission and 
discharge 
•  Generalized Anxiety Disorder 7 admission and discharge 
• Quality of Life in Epilepsy –31 and Quality of Life in Epilepsy –10 admission and 
discharge  
• Brief Illness Perception Questionnaire admission and discharge 
• The Sleep Condition Indicator admission and discharge 
• Montreal Cognitive Assessment at admission and discharge 
• EpiTrack at Admission and discharge 
• Number of seizures recorded in the first week (Focal and Generalised) 
• Number of seizures recorded in the last week (Focal and Generalised) 
• Number of PNES recorded in the first week 





There will be no novel data collection as part of this research. All data undergoing analysis has 
been collected as part of routine processes within the SEC. All data will be anonymised prior to 
being supplied to the researcher.  
 
The SEC gave approval for the researcher to have access to the anonymised dataset and to carry 
out the proposed analysis. Sponsorship of the study will be provided by the University of 
Glasgow and the school of Medical, Veterinary and Life Sciences has been satisfied with the 
ethical review conducted through the SEC. It was determined that NHS GG&C Research and 
Development did not require to carry out ethical review as the dataset will be fully anonymised 





Submission to NHS Research and 
Development  
November 2020 
Data Analysis November 2020 – December 2020 
Writing Up January 2021 – February 2021 
Submission February 2021 
 
Dissemination 
The research results will be published as part of the Doctoral Thesis by the trainee clinical 
psychologist, the results will be made available to the SEC and will be submitted to peer 
reviewed journal for publication. Although no conferences have been identified prospectively, 
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